An analysis of sociodemographic, dietary and environmental determinants of allergic rhinitis and atopic eczema symptoms among adolescents in Cape Town, South Africa : findings from the International Study of Asthma and Allergies in Childhood (ISAAC) by Dearham, Astrid Chrisilda
The copyright of this thesis vests in the author. No 
quotation from it or information derived from it is to be 
published without full acknowledgement of the source. 
The thesis is to be used for private study or non-
commercial research purposes only. 
Published by the University of Cape Town (UCT) in terms 



















An analysis of sociodemographic, dietary and environmental determinants of allergic rhinitis 
and atopic eczema symptoms among adolescents in Cape Town, South Africa: findings from 





Astrid Chrisilda Dearham 








Dissertation presented for the degree of Masters in Medicine (MMed) (Public Health) 
School of Public Health and Family Medicine 











2 | P a g e  
 






Structure of dissertation…………………………………………………………………………..….6 
Abstract…………………………………………………………………………………..……….…...7 
Parts and subheadings……………………………………………………………...…..……...…...9 
Appendix I………………………..………………………………………………...........................90 












3 | P a g e
I dedicate this dissertation to my late father, Isaac Dearham, as well as
my mother, Lenore. I am privileged to always have the incredible
support, faith and patience of my sister, Vania, my partner Kurt, other











4 | P a g e  
 
DECLARATION  
The work presented in this report represents analyses of data collected as part of a larger 
international multicentre collaborative study, the International Study of Asthma and Allergies 
in Childhood (ISAAC) Phase Three. Under the supervision of Professor R.E. Ehrlich, the role 
of the author was restricted to the data analyses of the specified conditions and the 
documentation of findings, presented as Parts of this dissertation. Therefore, the analyses 
presented in this dissertation are the original work of the author and have not been 
submitted for other degree purposes, or publication before. Where the work of others has 
been used (whether it has been quoted verbatim or paraphrased or referred to) it has been 
attributed and acknowledged using the Harvard referencing convention.  
 
 
Signature : ________________ 










5 | P a g e
ACKNOWLEDGEMENTS 
Firstly, I would like to convey my heartfelt gratitude to my supervisor Professor Rodney 
Ehrlich. Your wisdom, guidance and attention to detail have been humbling and invaluable 
lessons. To both Professor Rodney Ehrlich and Professor Heather Zar, thank you for the 
opportunity to use the ISAAC Phase Three data for my dissertation.  To Anna Grimsrud, 
thank you for the ad hoc statistical advice you have provided. 
As mentioned by authors who have used the ISAAC data of the Cape Town centre, once
again a word of appreciation is extended to the field researchers, the Dept. of Education in
the Western Cape, the school principals, teachers, children and parents for participating.
The study was supported by a grant from the Medical Research Council, South Africa, an
AstraZeneca Respiratory fellowship awarded by the South African Thoracic Society (Heather
Zar), and sponsorship from the following pharmaceutical companies: AstraZeneca,
Boehringer-Ingelheim, 3M and Schering-Plough. We thank the International ISAAC centre,










6 | P a g e
STRUCTURE OF THE DISSERTATION 
An abstract of the study is first presented. Thereafter there are 3 parts to the dissertation. 
Part A is the protocol that outlines the justification for the study, the methods and analyses 
as well as the ethical implications.  
Part B presents the findings of the literature review that was conducted. Current evidence on
the validation of the rhinitis and eczema ISAAC questionnaires as well as the relevant
sociodemographic, dietary and environmental exposures of the conditions individually and
together, is appraised. The influences of socioeconomic status and “upward mobility” are
also reviewed.
Part C concludes the dissertation in the format of a submission to the Journal of Allergy and
Clinical Medicine. The format deviates from the journal instructions in that line numbers have
not been included and, to maintain consistency between the Parts, the Harvard referencing
convention – and not Vancouver - has been used.
The key results of logistic regression analyses are presented for the outcomes of allergic
rhinitis and atopic eczema. Where possible, these are compared to the previous findings for
the outcome of wheeze.
References and appendices are at the end of the dissertation. Appendix I includes the
“Instructions to authors” as provided by the Journal of Allergy and Clinical Immunology as
well as the consent forms and questionnaires. Appendix II (the Online Repository for the
journal) includes the full outputs of analyses as well as additional results that were not














Most analyses of International Study of Asthma and Allergies in Childhood (ISAAC) data in 
developing countries have suggested an increase over time in 12-month prevalence of 
rhinitis and eczema symptoms amongst adolescents. Analysis of the Cape Town Phase 
Three data for the determinants of allergic rhinitis and atopic eczema symptoms has not yet 
been conducted.  
Objective 
To measure the sociodemographic, dietary and environmental risk factors of allergic rhinitis 
and atopic eczema symptoms amongst adolescents of the Cape Town centre of the ISAAC 
Phase Three study.  
Methods 
A cross-sectional study design using written questionnaires was performed in 2002. The 
study population included 5, 037 adolescents who attended 54 schools. Logistic regression 
with stepwise model-building was done. The findings were compared to the findings of 
wheeze symptoms that was also analysed using the same dataset.  
Results 
Totals of 20.7% (1, 043) and 13.3% (670) of the respondents reported experiencing 
symptoms of allergic rhinitis and atopic eczema respectively. 212 (4.2%) of respondents 
reported that rhinitis symptoms had a significant impact on their daily activities. Only 244 
(4.8%) respondents reported that they had experienced comorbid symptoms. In general, 
findings were suggestive of different social class gradients: a higher SES associated with 
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for both outcomes. Paracetamol use at least once a month was positively associated with all 
3 outcomes. A household member with TB was a predictor for both allergic outcomes. 
Cereal and maize consumption 3 or more times (versus less often or never) a week were 
predictors of both outcomes. “Commuting” students (from low SES areas to high SES 
schools) had 1.3 odds for the outcome of allergic rhinitis compared to those from the same 
low SES area but who attended low SES schools (OR 1.33; 95% CI 0.78-2.29). For the 
outcome of atopic eczema, the findings are suggestive of a protective effect; although to a 
lesser degree than the students from higher SES areas. 
Conclusion 
This is the first analysis of the Cape Town ISAAC data that has c mpared the determinants 
of allergic rhinitis and atopic eczema to previously analysed wheeze symptoms. The 
contribution of social class to allergic disease in South Africa is suggestive from these 
findings. Although frequent paracetamol use was associated with all outcomes and 
biologically plausible mechanisms are present, this study was unable to exclude reverse 
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The increase in allergic disorders amongst children has become a focal area for research 
and debate, especially around the contribution of dietary and environmental determinants. 
Intermittent research has been stimulated by the use of standardized instruments in The 
International Study of Asthma and Allergies in Childhood (ISAAC).  
ISAAC is a multicentre collaborative study that was first undertaken in 1992 to measure the 
prevalence of three allergic disorders through self-reported symptoms: asthma, 
rhinoconjunctivitis and eczema in school goers. Three phases were conducted from 1992 
onwards and the application of a standardised method by different centres in studies across 
the world has ensured that results can be compared (Asher 1995). 
Phase One studies were conducted between 1992 and 1995 in 56 countries and 
documented the baseline distribution of these three allergic conditions across all the centres 
participating in the study (Asher 1995; 1998). 
Phase Two was conducted in 22 countries, although not in South Africa, and aimed to 
provide further information on risk factors by conducting physical examinations and 
laboratory tests on the adolescents (Weiland 2004). 
Phase Three was conducted from 2002 onwards in 106 countries (Ellwood 2005). The 
illustration of a “world map” - as well as the documentation of trends in the prevalence of the 
three disorders - is now possible. 
Most analyses of ISAAC Phase Three data in developing countries have demonstrated 
substantial increases in the 12-month prevalences of all three allergic conditions. According 
to Odhiambo et al. (2009), “Trends in eczema symptoms... indicate that the prevalence of 
eczema is rising, especially in younger children, suggesting that environmental factors could 
be playing a key role in determining disease expression.” A similar increase in the 










15 | P a g e  
 
Asthma prevalence, its severity and predictors of risk have previously been analysed based 
on the ISAAC Phase One and Phase Three studies in Cape Town, South Africa (Poyser 
2002; Graham 2002; Mahlati 2007).  
Two reports have documented the prevalence of allergic rhinitis and atopic eczema in Cape 
Town. Using the ISAAC Phase One dataset, Mercer et al. (2004) analysed the prevalence of 
allergic rhinitis and atopic eczema symptoms by socioeconomic status (SES). The second 
report was written by Zar et al. (2007) who assessed trends in the symptoms of all three 
allergic conditions by using both ISAAC Phase One and Three data. Further analysis of the 
ISAAC Phase Three data in Cape Town for the predictors of risk of allergic rhinitis and 
eczema has not yet been conducted. Therefore, an opportunity arose to contribute to 
knowledge of the significant sociodemographic, dietary and environmental risk factors for 
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Background to the Western Cape province and Cape Town district 
The Western Cape province is located in the south west area of the Republic of South Africa 
(Figure 1). According to the Census survey of 2001 (Pretoria: Statistics South Africa 2005), 
there were 4,524,335 persons in the Western Cape (10.1% of the population of South Africa) 
at that point in time. There were 5 district rural municipalities. The City of Cape Town was 
classified as a metropolitan municipality. The boundaries of the rural districts have since 
changed.  
The Census 2001 revealed the following socidemographic findings. Afrikaans was the most
frequently spoken home language in the province, followed by English and then Xhosa.
Although the City of Cape Town – the study centre for ISAAC in the country - covers the
smallest surface area, it accommodated approximately 66% of the population in 2001.
Amongst those aged 13 to 14 years – the age group of the ISAAC population in the Cape
Town centre, approximately 95% were attending an educational institution. In both Censuses
of 1996 and 2001 amongst those aged 15 to 65 years in the province, the African and
Coloured population groups had higher pr portions of unemployment than other groups.
Lastly, 77% (920 000) of households lived in formal housing structures while 15.8%
(190 000) lived in informal structures such as shacks. A marker of social mobility is the
proportion of African-headed households who live in formal dwellings. This had increased
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Figure 1 Map of Western Cape District Municipalities (source: Annual Performance Plan 2010) 
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2. Justification for further research 
Prevalence trend of allergic rhinitis and eczema symptoms 
An analysis of ISAAC Phase One data in Cape Town demonstrated the 12-month 
prevalences of allergic rhinitis and atopic eczema symptoms to be 33.2% and 11.9% 
respectively (Mercer 2004), both higher than the worldwide Phase One medians that were 
reported (Strachan 1997; Williams 1999).  
A follow-up study using the ISAAC Phase Three survey of 2002 by Zar et al. (2007) found 
that the lifetime prevalences of both allergic rhinitis and eczema symptoms had increased 
significantly from Phase One; the former from 37.6% (1995) to 49% (2002) while eczema 
increased from 9.6% (1995) to 16.7% (2002). The 12-month prevalences of both symptoms 
had also increased in both males and females.  
Impact of allergic rhinitis and eczema symptoms 
As with asthma, although the symptoms of allergic rhinitis and atopic eczema may have a 
minimal impact on routine activities, the  may in some cases be distressing to the affected 
adolescent. In the comparison between ISAAC Phase One and Three, Zar et al. (2007) 
found that the reporting of both conditions, in their adverse impact on daily activities (for 
rhinitis) and night waking (for eczema) more than once a week, had increased. This was 
more substantial for rhinitis; in Phase One only 13% reported little impact on daily activities; 
in Phase Three this had increased to 26.2%. Moderate/severe impact increased from 9.3% 
to 11.6%. The direct and indirect effects (e.g. sleep deprivation and marital problems) and 
financial costs incurred by families who have a child with atopic eczema have been shown 
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Determinants of allergic rhinitis and eczema symptoms 
The concept of the atopic march - when a child with eczema progresses to asthma and 
rhinitis in adulthood – is widely accepted (Bergmann 1998; Spergel 2003). However, this 
concept as well as the belief in the common causation of asthma, eczema and rhinitis has 
been challenged by Williams et al. (2006; 2008). These authors suggest that not only may 
the “march” not be as straightforward as thought, but that the environmental risk factors may 
not be the same for the 3 allergic conditions. 
A Cape Town Phase Three thesis analysis of asthma (Mahlati 2007) suggested that the 
presence of the following environmental exposures had associations with the reporting of 
current wheeze: maternal and respondent smoking, being overweight for age and exposure 
to wood smoke. Exercise at least once a week and paracetamol (acetaminophen) used at 
least once a month were also found to have positive associations with asthma.  
Other environmental exposures such as truck traffic frequency and household smoking have 
been positively associated with not only asthma symptoms, but also those of 
rhinoconjunctivitis and eczema (Brunekeef 2009; Annesi-Maesano 2004). However, overall 
there appear to be a lack of consistency between the findings of studies conducted across 
the world with respect to these risk factors (Strachan 1998; Codispoti 2010). 
The effect of paracetamol use on allergic disorders in children is particularly well researched 
(Cohet 2004; Beasley 2010; Asher 2010). Positive associations between paracetamol use 
and allergic outcomes have been demonstrated in most studies although the nature of the 
study designs has limited interpretation of the associations.  
The influence of dietary factors such as starch, cereals, vegetables and seafood 
consumption on the symptoms of asthma, allergic rhinoconjunctivitis and atopic eczema 
have been explored with inconsistent results worldwide (Ellwood 2001; Huang 2001; Chatzi 
2009; Asher 2010). A protective dietary factor in one country may be a predictor for risk of 










20 | P a g e  
 
Variation by SES and social mobility 
The impact of the home environment (type of dwelling and overcrowding) and other proxy 
markers of SES such as maternal education for the risk and severity of allergic disease are 
important. The SES gradient is often positive. For example, a positive association was found 
between SES and the symptoms of rhinoconjunctivitis but not eczema in the Phase One 
Cape Town analysis (Mercer 2004). Mahlati (2007) also demonstrated a tertiary education of 
the mother to be one factor that consistently increased the odds of reporting wheeze 
symptoms and a diagnosis of asthma to be made greater. High parental education is also 
found to be a risk factor for diseases ever diagnosed by a physician as well as common cold 
symptoms in a study by du Prel et al. (2006).  
A marker of social mobility was examined by Poyser et al. (2002) in an analysis of Phase 
One asthma prevalence by school type. Three groups of adolescents were examined; low 
SES adolescents attending low SES schools, high SES adolescents at high SES schools 
and low SES adolescents (mainly Xhosa-speaking adolescents from low income areas) at 
high SES schools. Different results were found for the written and video questionnaires. In 
the former, the highest prevalences of asthma and recent wheeze were found amongst the 
high SES adolescents at high SES schools; in other words the most “affluent” adolescents of 
the three strata. However, in the video questionnaire, the prevalence of asthma symptoms in 
the last 12 months based on a five step video sequence was considerably higher amongst 
the low SES adolescents attending low SES schools; i.e. the “commuting” adolescents.  
After finding no significant association between urbanisation (duration of time in years in an 
urban area) and the prevalence of asthma symptoms, the authors suggested that upward 
mobility – demonstrated by the low SES adolescents commuting to attend schools outside 
their areas – might be a more relevant predictor of disease prevalence.  
Mercer et al. (2004) also found that there were higher prevalences for both rhinitis and 
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the highest SES areas. The Phase Three data have not been analysed using the above 
stratification. 
In summary, a study of the Cape Town Phase Three data would be valuable for the following 
reasons: to establish whether associations of sociodemographic, dietary and environmental 
risk factors with the symptoms of rhinitis and eczema are similar to those found for asthma; 
to determine whether adolescents with both symptoms of allergic rhinitis and eczema have 
the same risk factors as those for each condition individually and to confirm whether Phase 
One social mobility differences in disease are present in the most recent dataset. 
3. Research Aim
To investigate the prevalences of allergic rhinitis and atopic eczema symptoms (see
definitions below) and their associations with sociodemographic, dietary and environmental
risk factors in the 13 to 14 year old group of adolescents who were studied in the Cape
Town, South Africa centre of the ISAAC Phase Three study in 2002.
4. Objectives
a. To measure and analyse risk factors associated with the reporting of allergic rhinitis 
and atopic eczema symptoms in a population of adolescents in Cape Town, South
Africa using ISAAC Phase Three data.
b. To identify risk factors common to both conditions, as well as to current wheeze
symptoms that was analysed by another researcher in 2007 using the same dataset.
c. To measure and analyse risk factors amongst those adolescents with both allergic
rhinitis and atopic eczema (comorbid) symptoms.
d. To measure the influence of socioeconomic status (SES) and upward social mobility
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II. METHODS 
1. Definition of Terms 
a.  Allergic rhinoconjunctivitis (“allergic rhinitis”). This was defined by a positive answer 
to “Have you had problems with sneezing, or a runny, or blocked nose when you did 
not have a cold or the flu in the past 12 months?” and “In the past 12 months, has 
this nose problem been accompanied by itchy-watery eyes?” (ISAAC manual; 1993). 
 
b. Atopic eczema. Two questions were used to assess the prevalence of eczema: 
““Have you ever had this itchy rash at any time in the past 12 months?” and “Has this 
itchy rash at any time affected any of the following places: the folds of the elbows, 
behind the knees, in front of the ankles, under the buttocks, or around the neck, ears 
or eyes?” (ISAAC manual; 1993). 
 
c. Race, language, residence and social class. According to Jones (2001), race is a 
social construct and a crude “proxy to measure social class, culture and genes.” In 
South Africa, because of the segregation policies that were enforced and based on 
the perceived colour of one’s skin during the Apartheid era, there has been a 
continuation of collecting data according to these groups since they determined 
access to health care, residence, education and employment. The racial categories 
were: “White” (persons of European descent), “Black” (also known as “Africans”), 
“Coloured” (persons of perceived “mixed” race) or “Indian” (persons of Asian 
descent). Africans, who were predominantly Xhosa-speaking and Coloured persons, 
were more likely to live in urban areas known as “townships” that, apart from 
overcrowding, did either not have basic amenities in place or had services that were 
of a lower standard than Whites. Because the time period in which the ISAAC data 
were collected was relatively shortly after the achievement of democracy in 1994, 
race and its associated language and residential variables still hold high potential 
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identified in the Cape Town study and classification has been based on previous 
historical segregation; those that were attended by predominantly Xhosa-speaking 
adolescents; those that were attended by predominantly Coloured adolescents and 
located in “Coloured areas” and lastly, those formerly White only schools situated in 
high SES areas. The last category of school was attended by adolescents from all 
areas after 1994 and is referred to as “integrated” schools. 
 
d. Hygiene hypothesis. The hypothesis suggests that the higher rate of acquisition of 
allergic or autoimmune disease, or a higher prevalence of previously stable 
conditions in populations, may be attributable to a loss of protective immune factors 
that were previously induced by exposure to microbial agents in food and the 
environment. Clough et al. (2010) summarizes the hypothesis as “lower rates of 
exposure to certain kinds of allergens, bacteria and other microorganisms have had 
unintended, negative consequences for immune health”.  
 
2. Study Design 
In order to standardize the methodology to measure self- reported symptoms and diagnoses 
in 13 to 14 year old school children, a cross-sectional study design using standardized 
ISAAC written and video questionnaires was performed in 2002.  The study also made use 
of two written questionnaires as well as a video-based questionnaire which were completed 
by the students.  
 
3. Population and Sampling 
3.1 Study Population 
The study population in the ISAAC study included both male and female adolescents aged 
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3.2 Method of Sampling 
Since the school was the primary sampling unit, the standardised ISAAC methodology 
required that a minimum of ten schools be included in each centre. A stratified random 
sampling strategy was based on a list of Cape Town-based schools provided by the local 
Department of Education. The decision to stratify according to the predominant racial group 
at the school (White/integrated, Coloured or Black) was informed by the previous political 
environment that legislated such racial descriptions. Schools were divided into these 3 strata 
and then randomly selected. ISAAC Phase Three also required that all adolescents aged 13 
and 14 years from the selected schools be eligible whilst other ISAAC studies were adapted 
to include 6 and 7 year old children. In this study, adolescents in the two grades with the 
most 13 and 14 year olds in the schools were surveyed. To ensure that all eligible 
adolescents were included and that absenteeism was compensated for, each school was 
visited twice. 
3.3 Sample size 
The ISAAC methodology determined the sample size, which was calculated to be 3, 000 
children, for the outcomes of wheeze, rhinitis or eczema (Asher 1995). The size was based 
on the more severe atopic disease than the prevalence of disease of any severity. This size 
would ensure a power of 95% to detect a significant difference in prevalence in two centres 
with true prevalences of 25% and 30% respectively at the 1% significance level; and 90% 
study power to detect a significant difference in prevalence of severe asthma between 
centres with true differences of 3% and 5% respectively at the 1% confidence level. 
 
4. Measurement  
4.1 Instrument 
The ISAAC Phase Three methodology requires the use of the following three standardized 
and validated questionnaires (Appendices 1E to 1G) which are described in greater detail in 
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1. The core written questionnaire; 
2. The environmental written questionnaire; 
3. The video questionnaire 
The core written questionnaire consists of demographic questions as well as those that 
pertain to the prevalence of the symptoms of allergic rhinitis and eczema.  
The relevant questions to the intended analyses are listed below: 
Rhinitis 
1. Have you ever had a problem with sneezing, or a runny, or blocked nose when you 
did not have a cold or the flu? 
2. In the past 12 months, have you ever had a problem with sneezing, or a runny, or 
blocked nose when you did not have a cold or the flu? 
3. In the past 12 months, has this nose problem been accompanied by itchy-watery 
eyes? 
4. In the past 12 months, how much did this nose problem interfere with your daily 
activities? 
5. Have you ever had hay fever? 
 
Eczema 
1. Have you ever had an itchy rash which was coming and going for at least six 
months? 
2. Have you had this itchy rash at any time in the past 12 months? 
3. Has this itchy rash at any time affected any of the following places? (Options 
provided) 
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5. In the past 12 months, how often, on average, have you been kept awake at night by
this itchy rash?
6. Have you ever had eczema?
The environmental questionnaire was designed by the ISAAC Steering committee to provide 
information regarding dietary and environmental exposures. The ISAAC international centre 
did allow for the modification of the questionnaire either by excluding certain questions from 
the original questionnaire, or addition of questions on additional risk factors that are locally 
relevant.  
All in all, one dietary risk factor and eleven environmental exposure questions were added
for the Cape Town study. A question regarding maize was included as a dietary risk factor
as maize was, and still is, part of the staple diet for many South Africans. The additional
eleven environmental questions are listed below:
1. Do you smoke cigarettes?
2. Is your house damp or wet inside?
3. Has anyone in your household ever had TB?
4. Have you ever been treated for TB?
5. Do you have taps for running water in your house?
6. Do you have electricity in your house?
7. Do you have a TV in your house?
8. Type of home: House, Flat, Shack or Other
9. Number of people working in the household
10. Number of people not working in the household
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Since ISAAC questions of overcrowding, damp, access to tap water, fuel use and house 
type are both SES and environmental markers – and SES may be mediated through these 
variables -  it has been decided for the purposes of this study to limit the sociodemographic 
determinants to language, gender, education, employment, and access to television in the 
house. The rest of the variables will be considered as environmental factors. 
Lastly, the video questionnaire was included to reduce the language understanding and 
translation barriers that may be encountered with the written questionnaire. In the Western 
Cape province, Cape Town, there are three commonly used languages; English, Afrikaans 
and Xhosa.  The direct translation of some of the terminology, for example “asthma”, is 
prone to misinterpretation. Hence, the video questionnaire was used to reduce the potential 
misinterpretation relating to asthma. However, there is no video questionnaire for the 
outcomes of allergic rhinitis and eczema 
The following procedure for the questionnaire administration was recommended by the 
ISAAC Steering Committee (1993) i) The three questionnaires – the core written, the 
environmental and the video questionnaires – would be self-administered and the sequence 
to follow is to complete them in order all on the same day. ii) A facilitator would follow the 
standardised process and show the video at each school using the language that was the 
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III. ANALYSIS FOR THIS DISSERTATION 
1. Data Analysis 
A “stem and branch” question format was used in the core written questionnaire. For 
example, regarding rhinitis, “Have you ever had a problem with sneezing, or a runny, or 
blocked nose when you did not have a cold or the flu?” is a stem question, followed by “(if 
yes), In the past 12 months, have you ever had a problem with sneezing, or a runny, or 
blocked nose when you did not have a cold or the flu?” (branch question). Following a 
negative response to a stem question, the questionnaire prompts the participant to proceed 
to the next question. 
Therefore, the coding for stem questions could either be “yes (1)” or “no (2)” or “9 (missing)” 
if the question was skipped by the respondent. Contradictory responses will be excluded 
from analyses. For branch questions, prevalence will be calculated using as the denominator 
the sample that answered both the stem and branch questions. 
Analysis will be conducted according to the format of the question.  
To address the objective of analysis of allergic rhinitis and eczema outcomes according to a 
potential “commuting status” marker for SES mobility, the following steps will be carried out: 
a. The schools of the adolescents will be classified into either low SES or high SES 
based on the name and location of the school, as judged by the researcher.  
b. The SES status of the adolescents will be based on the residential suburb as 
provided by the participant. Those adolescents residing in the lower SES areas but 
attending schools in affluent areas will be classified as “commuters”. The comparison 
groups will be those adolescents residing in and attending schools located in the 
same area; that is, whether low SES or higher SES areas.  
2. Statistical analysis 
Stata version 11 (Stata Corporation) will be used to analyze the data.  
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a) One way frequency tables with measures of central tendency and dispersion will be
used for the demographic profiling.
b) Two way frequency distribution tables will be used to cross tabulate categorical
variables of interest.
c) Measures of central tendency (mean or median) and dispersion will also be used for
numeric variables.
d) Bivariate analysis with the odds ratio (OR), 95% confidence interval and p value, will
be conducted to measure associations between an exposure and the outcome
variable/s of interest.
e) Multivariate logistic regression will be performed by fitting statistically significant
predictors from the bivariate analyses and/or those of a priori relevance or interest
against the outcome variables of interest.
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IV. ETHICS & COMMUNICATION
1. Ethics
Ethics approval for the 2002 ISAAC study was granted by the Research Ethics Committee of 
the University of Cape Town (Ethics approval no. 203/2001) (Appendix 1B). As part of the 
process, the Western Cape Department of Health and the appropriate school principals were 
approached for permission for the study; a letter with an opt-out clause was also sent to the 
parents/guardians of the selected adolescents (Appendix 1C and 1D).  
2. Feed-back and Dissemination of this analysis
The findings will be submitted as part of the Master of Medicine (MMed): Public Health
dissertation at the University of Cape Town. It will also be submitted in the appropriate
format to a peer-reviewed journal. The findings will also be communicated to any special
interest reference groups affiliated to the Western Cape Provincial Department of Health as
well as the Maternal, Child and Women’s Health Directorate within the Department of Health
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I. OBJECTIVES OF THE LITERATURE REVIEW
1. To summarize the literature on the validation of ISAAC instruments used to measure the
prevalence of symptoms of allergic rhinitis and eczema.
2. To review the most pertinent sociodemographic, dietary and environmental risk factors
associated with allergic rhinitis and eczema.
3. To review the influence of upward social mobility on the symptoms of allergic rhinitis and
eczema.
II. REVIEW OF RELEVANT RESEARCH
1. To summarize the literature on the validation of ISAAC instruments used to
measure the prevalence of the symptoms of allergic rhinitis and atopic eczema.
The International Study of Asthma and Allergies in Childhood (ISAAC) - a multicentre
collaborative study - was undertaken to measure the prevalence of three allergic disorders
through self-reported symptoms: asthma, allergic rhinoconjunctivitis and eczema in school
goers. Since 1992, three Phases have been conducted worldwide (Asher 1995 and 1998;
Weiland 2004; Ellwood 2005).
As with asthma, the core written questionnaire (one of three of the methods) was designed 
to assess the prevalence and severity of current allergic rhinitis and atopic eczema 
symptoms.  
There have been concerns about the use of symptom-based questionnaires in ISAAC; 
particularly with the lack of a video component in rhinitis and eczema and the lack of a 
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1.1 Eczema symptoms 
In 2009, Flohr et al. used the Phase Two studies to compare the atopic eczema findings 
between the questionnaire and a physical skin examination for which a standardized 
protocol was used. Comparisons were done: i) at the level of the study centre to ascertain 
the validity of the questionnaire at a population level and, ii) at the level of the respondents to 
assess the questionnaire as a diagnostic tool. 
The analysis was done on 30,358 children aged 8 to 12 years from 25 study centres in 18 
countries. Ghana was the only African country that was included. 
The authors found that in all but one study centre (Pichincha, Ecuador), flexural eczema 
prevalence based on physical examination (mean 3.9%) was lower than prevalence 
estimates that were derived from the questionnaire (9.4%). At a population level, the 
correlation between the ISAAC Phase Two questionnaire and examined eczema was high 
and was sensitive to differences in eczema severity (r = 0.77, P < 0.001). At an individual 
level, there were approximately 8% of cases of flexural eczema that were diagnosed on 
physical examination but not detected by questionnaire, which was not a concern. However, 
amongst the group who answered positively to the symptom of “Persistent flexural rash in 
the past 12 months?”, there was a bigger proportion of cases (range 0.0% to 66.7% between 
study centres) that were not confirmed as flexural eczema on physical examination.  
Likely contributory factors to these discrepancies include the following: i) Language and 
cultural differences without the aid of a video component could lead to misinterpretation of 
the questions; ii) The skin examinations were done by field workers and not dermatologists 
nor paediatricians; darker skin colours may lead to the condition being missed by a less 
experienced examiner; iii) Other pruritic skin conditions such as scabies may be reported as 
being eczema; and lastly, iv) Although the areas of buttocks and ears were part of the 
flexural areas in the written questionnaire, they were not included in the physical 
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examination was based on the U.K. diagnostic criteria for atopic eczema which was only 
finalised after the ISAAC symptom-based questionnaire was drawn up.   
In this regard, Czarnobilska et al. (2010) found that the ISAAC questionnaire was not 
specific enough to distinguish between atopic eczema, allergic contact dermatitis and other 
eczematous conditions. However, these findings were limited by the small sample size 
(n=143) as well as the recall bias of the respondents.  
The United Kingdom Working Party (UKWP) criteria (also known as the UK diagnostic
criteria) is another diagnostic tool that consists of a combination of standardized questions
(used as part of the eczema core written questions of ISAAC) and a set of reference
photographs. The original criteria consist of one mandatory and five major criteria; a
diagnosis of atopic eczema is made with the fulfilment of a positive itch plus three criteria
(Brenninkmeijer 2008).
Variable results between the UKWP criteria and ISAAC surveys for eczema have been
summarised by Strina et al. (2010) and Brenninkmeijer et al. (2008) as being due to: the
intermittent nature of the condition; the mild forms of eczema prevalent in the community that
differ from those that present to health care facilities; recall bias among the parents and
children and a denial of itching history by the parents; differences in study characteristics as
well as different reference standards; different periods of prevalence to establish the
diagnosis of eczema, and areas with a higher prevalence of scabies and other skin
conditions than that of eczema.
The findings of the study showed that the prevalence estimates using the ISAAC 
questionnaire (11.3%) were almost twice the estimates of the UKWP protocol (5.9%).  
A local Cape Town study of the point prevalence of atopic eczema using a modified version 
of the UKWP diagnostic criteria as well as a clinical assessment by a dermatologist also 
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clinical examination was 1.0% while the one-year prevalence according to the UK modified 
criteria was 1.8%.  
However, the authors also noted that apart from one sign (presence of visible flexural 
eczema according to UKWP photograph), the use of the UKWP criteria as a diagnostic tool 
for atopic eczema was difficult to implement in a Xhosa-speaking population. Cultural 
understanding and translation issues were the main factors that were identified. Still, the 
sensitivity and specificity of the U.K. criteria compared to clinical diagnosis in this setting 
were relatively good at 43.7% and 97.9% respectively. The positive and negative predictive 
values were 18.4% and 99.4%.  
The finding by Chalmers et al. (2005) that the UKWP photograph of flexural eczema was 
consistent with the clinical diagnosis, was confirmed by Haileamlak et al. (2005) who found 
in a cross-sectional survey in Ethiopia that the sign of visible flexural dermatitis examined for 
by a physician had higher positive and negative predictive values (57% and 91% 
respectively) than the ISAAC questionnaire (48.8% and 90.5%) and the UK criteria (55.5% 
and 90.1%). The authors admit that a limitation was their inability to examine the children 
within one week of the completion of the questionnaire which is the recommended time 
interval for assessing the symptom-based questionnaires against a point-prevalence based 
on a single physical examination. Extending this time interval by as much as two months 
meant that the physical signs of eczema may have either relapsed or now appeared.  
1.2 Rhinitis symptoms 
In 2009, the ISAAC questionnaire for allergic rhinitis and the Score for Allergic Rhinitis 
(SFAR), a questionnaire that assigns a quantitative score for allergic rhinitis in the absence 
of a medical visit (Piau 2009), were validated against the diagnosis made by a physician. 
The study was conducted on 597 adults and children in six countries: Morocco 
(Casablanca), Tunisia (Tunis) and Syria (Damascus), Ivory Coast (Abidjan), Congo 
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Apart from Guinea which had not significant findings, the SFAR had a much higher 
sensitivity than ISAAC across the board. The specificity of ISAAC was higher in 4 out of the 
6 countries with no significant differences in 3 instances. However, the study had several 
limitations; the most important being that respondents were recruited from hospital clinics 
and may not be representative of the general population that ISAAC was intended for. Also, 
the mean age was 29.8 years (range 10.3 to 36.1) amongst the six countries; affecting the 
external generalizability of the findings, specifically to children and young adolescents.  
In general, the ISAAC questionnaire appears to have a lack of specificity for its assessment
of both symptoms. This is greater for the eczema component. However, this is offset by its
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Congo 0.73 0.94 −0.21 (0.01) 0.98 0.84 0.14 (NS) 
Guinea 0.79 0.6 0.19 (NS) 0.48 0.78 −0.30 (NS)
Ivory Coast 0.40 0.97 −0.57 (<0.0001) 1 0.7 0.30 (0.001) 
Morocco 0.60 0.93 −0.33 (<0.0001) 0.84 0.56 0.28 (NS) 
Syria 0.47 0.97 −0.50 (<0.0001) 0.84 0.64 0.20 (NS) 
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2. To review the most pertinent sociodemographic, dietary and environmental 
risk factors associated with allergic rhinitis and atopic eczema. 
 
In general, the studies to measure and describe the determinants of allergic rhinitis and 
atopic eczema in children have been numerous, diverse and to a large extent contradictory 
in their findings (Torres Borrego 2008). 
2.1 Diet 
Dietary factors are an important consideration in the epidemiology of disease, especially 
non-communicable diseases. The antioxidant properties of foodstuffs (Ellwood 2001), trans-
fatty acids (Weiland 1999, Asher 2010) and lineoleic acids in polyunsaturated fats have been 
the areas of focus for allergic diseases, in particular asthma and rhinitis.  
In 2001, Ellwood et al. (2001) found in an ecological analysis significant (unadjusted for GNP 
though) protective associations between the outcomes of both allergic rhinoconjunctivitis and 
atopic eczema and i) calories from cereals and rice and ii) protein from cereals and nuts.  
There was also a protective association between vegetables and the symptoms of atopic 
eczema. This was particularly evident in the 13 to 14 year old age group. When adjusted for 
GNP, the protective associations for these and other categories such as seafood, all fish and 
olive oil, persisted although the significance waned.  
In contrast, findings from the cohort of the Osaka Maternal and Child Health Study (Miyake 
2007) showed no association of consumption of meat, eggs, and dairy products with the 
study definition of allergic rhinitis (either had received treatment with medications at some 
time in the previous 12 months or had another condition known as Japanese cedar 
pollinosis). A weak but significant protective and independent association was found 
between specific types of fatty acids (eicosapentaenoic and docosahexaenoic acids) and 
allergic rhinitis. Contrary to the ecological study of Ellwood et al., fish intake was not a 
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In the analysis of asthma in the current ISAAC study, Mahlati (2007) found that maize 
consumption was consistently negatively associated with current wheeze. The fortification of 
maize-meal and other food products with micronutrients that have antioxidant properties and 
that may lessen the inflammatory response, may explain the negative associations with 
rhinitis and eczema. In contrast, eating pasta once or twice a week (compared to never 
eating pasta) increased the odds of current wheeze. 
The consumption of fast food in relation to allergic disorders and atopy is an interesting 
potential risk factor. In New Zealand, Wickens et al. (2005) found that even “less than once a 
week” hamburger (defined as a beef mince patty in a bread roll) consumption was an 
independent predictor of current wheeze (adjusted OR 1.81, 95% CI 1.10–2.98) and having 
a history of wheeze (adjusted OR 1.65, 95% CI 1.07–2.52). Takeaway consumption (did not 
show an effect on any of the three outcomes. The intake of fast food may be a marker of 
high SES but other factors such as the salt content need to be considered in the 
interpretation of the associations with allergic disorders.  
In conclusion, current epidemiological studies are inconclusive on the role of different food 
types and their association with allergic rhinitis and eczema. Starch and cereal foodstuffs as 
well as seafood are the dietary factors that may have a protective influence on the two 
allergic conditions. Fast food consumption may be a risk factor.  
2.2 Body Mass Index (BMI)  
The relationship between obesity and allergic disorders is topical but not straightforward.  
Leptin, an adipocyte-derived protein hormone, is thought not only to be involved in body 
weight regulation but also in the immune response (Quek 2010). Previous studies have 
suggested that children who were overweight as measured by higher leptin levels were at an 
increased risk of asthma (Guler 2004).  
Quek et al. (2010) found that the higher BMI and serum leptin levels were associated with 
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study in Japan (Yoshida 2010) were consistent with the findings of Mahlati (2007) - their 
results suggested a positive association between being overweight (definition for exposure 
was above 90th percentile of BMI for age and gender) and the prevalence of current wheeze 
in adolescents. The association with the symptoms of current rhinoconjunctivitis was not 
statistically significant. However, the lack of temporality associated with a cross-sectional 
study design poses a challenge in the interpretation of findings.  
Other studies such as Kajbaf et al. (2011) and Vlaski et al. (2006) were unable to find a
significant association between being overweight and symptoms of wheezing, rhinitis or
eczema. Both studies instead found significant associations with “dry night cough”, a non-
specific sign of asthma.
Other conditions such as gastro-oesophageal reflux and obstructive sleep apnoea, that are
associated with being overweight, may mimic respiratory symptoms; hence the association
with this non-specific sign but not others of asthma. In conclusion, the evidence presented
for obesity or overweight-for-age as a strong risk factor for any of the three allergic
conditions is not convincing.
2.3 Home environment
The degree of protection or risk of an urban or rural environment associated with allergic 
conditions, whether as part of upbringing or current residence, differs between countries.
This may be due to the definitions applied in different studies as well as the influence of
other exposures such as population genetics and environmental factors (Nicolaou et al.
2005).
The role of the home environment in the development and severity of allergic conditions is 
well known. In a diverse and inequitable country such as South Africa, not all people live in 
housing that is protective against the weather elements.  
Ibargoyen-Roteta et al. (2007) found that exposure to moisture and mould on the house 
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symptoms, but not those of atopic eczema. With multivariate analysis, the effect of moisture 
on walls was attenuated but still significant.  
Mahlati (2007) found that living in a shack (compared to a house) and overcrowding were 
inversely associated with the outcome of current wheeze and an asthma diagnosis on the 
written questionnaire. However, both variables were attenuated in the multivariate analysis. 
A 2005 Ethiopia study (Haileamlak 2005) found that the risk of atopic eczema was unrelated 
to family size and overcrowding at home but was inversely related to access to piped 
drinking water. The latter also confirmed the findings of increased odds of the condition with 
better parental education (secondary schooling adjusted for age, sex and site OR1.65, 95% 
CI 1.07-2.55). Drinking from the river which is associated with a lower SES is thought to 
have a protective effect through increased exposure to enteric infections. 
The benefits for allergy of a more rural upbringing were also demonstrated in a Swedish 
cross-sectional study (Eriksson 2010) of 16 to 75 year old respondents. Living on a farm for 
the first five years of life was associated with a lower prevalence estimate of allergic rhinitis 
(20.1%) than those who were not raised in a farming environment (28.0%). This prevalence 
increased with increasing degrees of urbanization (from rural area to small town to mid-sized 
town to metropole). Endotoxin, part of the cell wall of Gram-negative bacteria, is thought to 
be the main factor respons ble for the protective effect of the farming environment. Exposure 
to endotoxin and similar components are thought to enhance the non-allergenic T-helper 1 
response to a greater extent than T-helper 2. The study does suffer from traditional cross-
sectional design flaws and the authors admit that they did not measure exposures such as 
parental smoking habits, history of childhood infections and number of siblings. Despite this, 
the protective effect of childhood farm living in relation to allergic rhinitis and in particular on 












42 | P a g e  
 
2.4 Gender 
Osman et al. (2007) found that for both asthma and rhinitis, the initial male predominance 
observed in childhood reversed at adolescence. The female predominance for eczema was 
noted to be earlier at 5 years of age but peaked considerably around adolescence. Despite 
these gender-specific presentations of allergic outcomes, the variable of gender on allergic 
disease, especially with respect to the ISAAC data, is not thoroughly explored in many 
studies.  
Possible explanations for an excess of female self-reporting of general physical and 
psychological symptoms at adolescence (Sweeting 2003) include the following influences: 
normal physical and maturational cycles which may be more positive for boys than females; 
societal influences on gender roles (Osman 2007); different coping mechanisms and 
different perceptions of symptoms (Hetland 2002). 
2.5 Smoking 
Study of the effects of passive smoking on allergic disorders in older children and 
adolescents has also yielded conflicting results (Torres-Borrego 2008).  Some studies such 
as Annesi-Maesano et al. (2004) have reported significant positive associations with all three 
allergic conditions, others show positive findings for respondent smoking only (Burr 1999) 
and while studies of Raherison et al. (2006), Strachan et al. (1998) and Vlaski et al. (2010) 
show no associations at all.  
Using the self-reported data from ISAAC Phase Three of the Skopje centre, Republic of 
Macedonia, Vlaski et al. (2010) found that apart from the significant finding of maternal 
smoking and current night dry cough adjusted for confounders such as gender, educational 
level etc. (OR 1.03, 95% CI 1.03-1.54) no significant associations existed between smoking 
variables and eczema or rhinitis. The authors cite information bias as a possible limitation in 
their findings as the adolescents may not have fully understood the questions. The 
environment of the country is also such that children are more likely to be outdoors and 
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absence of any associations may be an accurate reflection as, despite reported high tobacco 
smoking estimates in the country, the prevalence of both symptoms is very low (prevalence 
of rhinoconjunctivitis symptoms 5.8% and current eczema symptoms 2.7%).  
Although they do not report the actual prevalences of rhinitis and eczema, Raherison et al. 
(2006) state that they found no association between exposure to environmental tobacco 
smoke (ETS; represented by parental smoking habits in the study) and recent allergic rhinitis 
in children. Contrary to expectation, they also report finding a negative association between 
current ETS exposure and lifetime hay fever (defined as a history of hay fever at least once 
in life) and eczema. 
The effect of smoking thus appears to depend on whether it is active (the respondent) or 
passive and the exposure patterns. Parents may temporarily cease smoking while their child 
is ill or smoke but not in the immediate vicinity of the child. This may result in 
misclassification of exposure as there may be overestimation of the children’s exposure to 
smoke.  
2.6 Truck traffic frequency 
Truck traffic is another interesting environmental risk factor as it may affect these allergic 
conditions through several mechanisms. These could be either inflammatory or adjuvant 
pathways that may cause or aggravate symptoms by allergic sensitisation. Alternatively, 
truck traffic may be a marker of deprivation and be a contributory cause of stress which may 
aggravate an allergic condition such as eczema.  
Brunekeef et al. (2009) conducted an ecological analysis of 238 centres in 98 countries (513, 
087 children) for which data on self-reported truck traffic exposure was reported. In Africa, 
31.6% of 13 to 14 year old children reported “high” exposure (almost the whole day) 
compared to only 7.9% reported in Western Europe. After adjustment for a variety of 
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rhinoconjunctivitis (OR 1.39, 95% CI 1.27-1.52); as well as eczema (OR 1.54, 95% CI 1.37-
1.73).  
In contrast, although only followed to 3 years of age, the Cincinnati Childhood Allergy and Air 
Pollution Study (CCAAPS), a prospective birth cohort study of children born to atopic 
parents, found no association between exposure to Elemental Carbon Attributable to Traffic 
(ECAT) in infancy and allergic rhinitis or atopy (Codispoti 2010).  
2.7 Acetaminophen (paracetamol) 
Acetaminophen is yet another risk factor that has been explored in ISAAC. Several 
mechanisms of action that paracetamol exerts on allergic conditions have been postulated
(Farquhar 2009). These include a depletion of glutathione-dependent enzymes which may
impair antioxidant defences but also lead to a greater T-helper type 2 cytokine production,
predisposing to an allergic response. An alternative mechanism is via suppression of the
natural immune response (predominant T-helper type 1 response) when pyrexia is
dampened. Both mechanisms will either lead to an exacerbation of allergic conditions such
as rhinitis and eczema or prolong the recovery from the condition. Twenty years ago,
Graham et al. (1990) demonstrated in a randomized controlled trial that both aspirin and
acetaminophen were significantly associated with a suppressed antibody response. Prymula
et al. (2009) confirmed the reduced antibody response when acetaminophen was 
prophylactically administered at the time of vaccination.
Beasley et al. (2010) found that there was an exposure-dependent increased risk of current 
symptoms of rhinoconjunctivitis and eczema when paracetamol was used in adoescents. 
The population-attributable risk (PAR) for current symptoms of rhinoconjunctivitis and 
eczema associated with current paracetamol use was calculated as 36% and 40% 
respectively, assuming that the associations are causal. This association was independent 
of the presence of asthma although the authors recognised that the findings could be limited 
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In 2000, Newson et al. showed in an ecological study that there was a positive significant 
association between high prevalences of allergic outcomes in English-speaking ISAAC 
countries and national paracetamol sales. However, after controlling for the effect of these 
countries, with the exception of atopic eczema in adolescents, these associations were 
attenuated and became non-significant. 
More recently, the Cape Town Phase Three asthma analysis by Mahlati (2007) suggested 
that paracetamol used at least once a month had an association with the reporting of current 
wheeze (multivariate analysis OR 1.2, 95% CI 1.0- 1.4). Elsewhere, Cohet et al. (2004) also 
found that recent use of paracetamol at least once per month was associated with 
rhinoconjunctivitis but not eczema amongst 6 to 7 year old children in New Zealand. 
Asher et al. (2010) also demonstrated on an ecological level a small but positive association 
of rhinitis and eczema with paracetamol use.  
In conclusion, there is biological plausibility for the positive association of paracetamol use 
with allergic rhinitis and atopic eczema. The conflicting results of current studies suggest the 
need for a stronger study design and methods that reduce the confounding and other 
biases. This evidence may have been provided by Lowe et al. (2010) who found in a 
prospective cohort study that the association between paracetamol use and an increased 
risk of asthma disappeared after i) adjustment for history of early infections and ii) restriction 
to paracetamol use for non-respiratory tract illness. This also applied to the outcomes of 
rhinitis and eczema. 
2.8 Tuberculosis 
In 1997, Shirakawa and Enomoto found an inverse association between the prevalence of 
allergic disease and delayed hypersensitivity to Bacille–Calmette–Guerin (BCG) vaccination 
in children. It was in keeping with the thinking that a stimulated T-helper type 1 response 
would curb the atopic pathway (Steenhuis 2007). Steenhuis et al. (2007) were unable to 
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infants after the 6-week administration of BCG compared to the placebo group. However, the 
BCG group did demonstrate a trend towards less eczema (RR 0.72, 95% CI 0.5–1.0) and 
significantly less use of medication for eczema (RR 0.58, 95% CI 0.3–1.0) than the placebo 
group at the age of 18 months. 
Miyake et al. (2007) found that in 6 to 7 year old children, positive tuberculin reactivity was 
protective for atopic eczema symptoms but not allergic rhinoconjunctivitis symptoms.  
In contrast, Soysal et al. (2008) conducted a study amongst 347 household contacts (mean
age 8 years, SD 4 years) of adult patients with sputum smear-positive pulmonary TB. They
reported no significant difference between the frequencies of “ever wheeze”, “ever asthma”,
allergic rhinitis symptoms and atopic dermatitis symptoms in BCG scar-negative and –
positive contacts. This suggests M. tuberculosis infection may not have the protective effects
on the development of atopy as speculated in other studies.
The strains of BCG (Miyake 2007), the timing of the mycobacterial inhibition of atopy in life
(Soysal 2008) as well as the influence of environmental factors on the strength and different
mechanisms of immune response are factors to consider in the role that TB plays in allergic 
disease.
3. To review the influence of upward social mobility on the symptoms of allergic
rhinitis and atopic eczema.
Maternal education is often used as a proxy measure of SES. A tertiary education for the 
maternal caregiver (versus not a tertiary level) was a risk factor for the outcomes of current 
wheeze and an asthma diagnosis on the written questionnaire. These associations suggest 
that a higher SES provides individuals with not only the means to access health care and be 
diagnosed earlier but that they are more likely to report symptoms that someone with lower 
SES may not perceive as a priority. The protective effect of a low SES may be due to the 
development of atopy by an increased exposure to microbial agents in poorer living 
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A Swedish cohort study (Braback 2005) found that although low SES was a risk factor for 
asthma and protective for allergic rhinitis, steep increases in both conditions across three 
succeeding birth cohorts were observed amongst this group. Compared to the high SES 
group, the inverse association between low SES and rhinitis was becoming weaker: 1952-
1961 cohort, OR 0.79 (0.77–0.81); 1962-1971 cohort, OR 0.83 (0.82–0.86) and 1972-1977 
cohort, OR 0.92 (0.90–0.94). The authors felt that this demonstrated a more improved social 
class effect as there had been a dramatic improvement in the standard of living in Sweden; 
promoting allergic disease according to the hygiene hypothesis.  
Thus far, two studies of the Phase One Cape Town centre ISAAC data have found
associations between the students from low SES areas attending schools located in higher
SES areas and the outcomes of recent wheeze, rhinitis and eczema (Poyser 2002; Mercer
2004). In Poyser et al. (2002), although the written questionnaire showed that the highest
prevalences of asthma and recent wheeze were found amongst the higher SES students
attending high SES schools, in the video questionnaire the prevalence of asthma symptoms
in the last 12 months was considerably higher amongst the low SES students attending high
SES schools; i.e. the “commuting” adolescents.
Other ISAAC studies that have measured social mobility in terms of residence and schools
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III. LITERATURE REVIEW: CONCLUSION 
 
In conclusion, the literature reviewed for the validation of the ISAAC instruments 
demonstrates that, despite not having an adequate specificity, the symptom-based 
questionnaire of ISAAC for both eczema and rhinitis is sensitive for use at a population level 
and has brought an element of standardisation to the assessment of allergic conditions in 
different countries. In the case of atopic eczema, the addition of photographic materials such 
as in the UKWP would have required extra resources (e.g. staff training) and may not have 
increased the specificity of the questionnaire substantially. For rhinitis, deficiencies such as 
translation and cultural interpretation could have been reduced with a video component as 
was done for the symptoms of asthma. 
In general, the main dietary exposures of starch, cereal and seafood appear to be protective 
while fast food consumption a risk for allergic symptoms. Factors such as the cultural 
understanding of the food stuffs in the questionnaire, the portions that are consumed to 
constitute consumption to be a risk or protective and the role of diet amidst other influences 
(sociodemographic and environmental) are still unanswered.  
The association between o erweight-for-age and allergic disease may be confounded by 
other medical conditions that mimic the symptoms of allergic disease.  
Environmental exposures such as truck traffic frequency, smoking and the use of 
paracetamol have biologically plausible mechanisms for positive associations with the 
outcomes.  
An inverse association between socioeconomic status and allergic disease may exist. 
Previous ISAAC Phase One Cape Town studies of the “upwardly mobile” group have shown 
evidence of this association. Although the numbers of this group of students was small, it 
does warrant an assessment of Phase Three data as there appears to be a paucity of 
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ISAAC Phase Three data has not yet been analysed in terms of rhinitis and eczema 
outcome measures and further analysis of this data may yield findings that could assist in 
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I. INTRODUCTION
Concerns about increasing allergic disease in both developed and developing countries 
have stimulated extensive research in the past two decades. The three phases of the 
International Study of Asthma and Allergies in Childhood (ISAAC) in study centres 
throughout the world have provided a standardized methodology and the means to conduct 
baseline prevalence studies of rhinitis, eczema and asthma in school goers (Asher 1995 and 
1998) as well as to measure the determinants of variation between study centres (Weiland 
2004; Ellwood 2005). 
The Cape Town centre participated in Phases One and Three of ISAAC. Using this data, a
significant increase in the lifetime and 12-month prevalence of both allergic rhinitis and
eczema symptoms has been shown (Zar 2007).
In general, there have been inconclusive findings for many of the possible determinants of
the outcomes of rhinitis and eczema across study centres (Ellwood 2001; Huang 2001;
Chatzi 2009; Asher 2010). Analysis of the Cape Town dataset for the predictors of risk of
rhinitis and eczema has to date not been conducted.
The research aim of this study was therefore to investigate the association of allergic rhinitis
and atopic eczema symptoms with sociodemographic, dietary and environmental risk factors
in the 13 to 14 year old group of adolescents who were studied in the Cape Town, South
Africa centre of the ISAAC Phase Three study.
Objectives of the study were to: 
a. To measure and analyse risk factors associated with reported allergic rhinitis and
atopic eczema symptoms.
b. To identify risk factors common to both conditions, as well as to current wheeze
symptoms that was analysed by another researcher in 2007 using the same dataset.
c. To measure and analyse risk factors amongst those adolescents with both allergic
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II. METHODS
A cross-sectional study design using standardized ISAAC written and video (for asthma) 
questionnaires was performed in 2002.  The study population in the ISAAC study included 
adolescents who attended randomly selected schools from 3 racially constituted strata in 
Cape Town. Each school was visited twice to ensure that all eligible adolescents that may 
have been skipped as a result of absenteeism were included. 
Ethics approval for the 2002 ISAAC study was granted by the Research Ethics Committee of 
the University of Cape Town. All relevant stakeholders were also consulted and approached 
for permission.  
Data analysis was done using Stata version 11.1 software (Stata Corporation, June 2010).
Logistic regression with stepwise model-building was done until the best model, including
sociodemographic, dietary and environmental variables for each outcome of allergic rhinitis 
and eczema, was selected.
A marker of upward mobility was analysed using “commuting status” of the adolescents. The
study schools were classified into low SES or high SES based on the name and location of
the school, as judged by the researcher. Thereafter, the residential suburb as provided by 
the participant was classified into “low” or “high” SES. Those adolescents residing in the
lower SES areas but attending schools in affluent areas were classified as “commuters”. The
comparison groups were adolescents residing in and attending schools located in the same















3.1 Background characteristics of respondents 
The analysis was conducted on 5, 037 respondents from 54 schools in the Cape Town 
Metropole district. A total of 59.5% (2, 995) of the respondents were female and English was 
the predominant language of instruction at the sampled schools (40.9%). Only 18.5% (934) 
of the respondents were not born in Cape Town. The most prevalent maternal educational 
level that was reached was high school (58.8%) and 11.4% of respondents lived in an 
informal dwelling (shack). All the prevalence estimates are available in the Online 
Repository: Table i-iii (Appendix II). 
3.2 Prevalence of rhinitis, eczema and comorbid outcomes 
Totals of 20.7% (1, 043) and 13.3% (670) of the respondents reported experiencing 
symptoms of allergic rhinitis and atopic eczema respectively. 212 (4.2%) of respondents 
reported that rhinitis symptoms had a significant impact on their daily activities.  
Table 2: Core written questions and Rhinitis symptoms 
Symptom n N Percentage (%) 
Ever rhinitis 2, 466 5, 037 49.0 
Rhinitis in past 12 months 1, 939  38.5 
Rhinitis and conjunctivitis in past 12 
months 
1, 043  20.7 
Hayfever ever 2, 088  41.5 
Impact on daily activities: 
Not at all 
A little 
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Table 3 Core written questions and Eczema symptoms 
Symptom n N Percentage (%) 
Ever itchy rash 1, 318 5, 037 26.2 
Itchy rash in past 12 months 975 19.4 
Itchy rash in flexural areas on body 670 13.3 
Eczema ever 839 16.7 
Sleep disturbed in past 12 months: 
Never in the past 12 months 
Less than one night per week 




5, 037 18.8 
9.9 
5.8 
In all, 436 (8.7%) of 5, 037 respondents reported that they had experienced symptoms of
both rhinitis and eczema in the past 12 months (not shown). Females comprised 74.1%
(323) of this group. Fewer respondents reported that they had experienced both allergic
rhinitis and atopic eczema symptoms: 244 (4.8%). No other striking findings were noted from 
this comorbid group.  
3.3 Comparison of bivariate associations of allergic rhinitis, eczema and 
wheeze symptoms with selected sociodemographic, dietary and environmental 
exposures 
Tables 4, 5 and 6 present the bivariate associations of selected sociodemographic, dietary 
and environmental factors associated with the outcomes measures. The findings of Mahlati 
(2007) for the outcome of current wheeze (wheeze in the past 12 months) on the written (not 
video) questionnaire were reported alongside those of allergic rhinitis and atopic eczema for 
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and v in the Online Repository (Appendix II). The increased specificity of the outcomes (see 
“Definitions”) has meant that statistical power is reduced. 
In this analysis (Table 4), Xhosa compared to the reference category of Afrikaans was a 
stronger risk factor for eczema. English as the medium of instruction compared to Afrikaans 
at schools was a risk factor for all three outcomes.  
Male gender was inversely associated with both allergic rhinitis and atopic eczema; wheeze 
was not associated with gender (Mahlati 2007). Tertiary maternal education was suggestive 
as a risk factor for allergic rhinitis and wheeze outcomes but protective for atopic eczema. 
People employed in the household appear to be a risk factor for both allergic rhinitis and 
wheeze; while unemployed household members is suggestive to be a risk factor for atopic 
eczema.  
Tables 5 and 6 below present selected bivariate analyses of environmental and dietary
variables.
Despite a lack of statistical power, the use of wood (including open fires) for cooking and
heating was a predictor of the odds of all three outcomes. The use of wood (including open
fires) for cooking was statistically significant when the outcome was all-cause rhinitis (OR
1.89 95% CI 1.20-2.97). The use of paraffin for cooking and heating– suggestive of low SES
– was a statistically significant risk factor for rhinitis and eczema.
In general, measures such as access to electricity and taps were suggestive of risk factors 
for allergic rhinitis and wheeze but protective for atopic eczema.  
A shack dwelling (reference category: house) was positively associated with atopic eczema 
but protective for wheeze.  
The positive effect of Paracetamol (use at least once a month) as a risk factor was 
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allergic rhinitis outcome, maternal cigarette smoking and smoking by the respondent appear 
to be risk factors for the outcomes of allergic rhinitis and wheeze. 
Having received treatment for TB or having a household member who has had TB were 
significant predictors of odds for atopic eczema. 
Significant effects of some of the dietary factors were observed with an intake of three or 
more times a week (versus less often or never). However, apart from pulses, pasta, cereals 
and maize which showed a similar trend for at least two of the outcomes, the rest of the 
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Table 4: Bivariate associations of allergic rhinitis, atopic eczema and wheeze symptoms with selected sociodemographic exposures 
 Allergic Rhinitis Atopic Eczema Wheeze (Mahlati 2007) 
Exposure n N OR 
(95% CI) 
n N OR 
(95% CI) 
n N OR 
(95% CI) 
Language of instruction 
Afrikaans 258 1, 289 1.00 99 1, 289 1.00 204 1, 289 1.00 
Xhosa 297 1, 689 1.40 (1.15-1.71) 352 1, 689 4.22 (3.28-5.42) 224 1, 689 0.8 (0.6-1.0) 
English 488 2, 059 1.43 (1.20-1.72) 219 2, 059 1.89 (1.46-2.45) 597 2, 059 2.1 (1.8-2.6) 
Sex 
Female 701 2, 995 1.00 455 2, 995 1.00 - 2, 995 1.00 
Male 339 2, 026 0.61 (0.53-0.71) 211 2, 026 0.60 (0.50-0.73) - 2, 026 - 
What level of education has your mother reached or completed? 
Primary 
school 
- 4, 115 1.00 - 4, 115 1.00 - 4, 115 1.00 
211 922 1.04 (0.87-1.27) 129 922 0.91 (0.73-1.13) 192 922 1.03 (0.86-1.24) 
Secondary 
school 
- 2, 077 1.00 - 2, 077 1.00 - 2, 077 1.00 
601 2, 960 0.94 (0.81-1.09) 383 2, 960 0.91 (0.76-1.09) 558 2, 960 0.80 (0.69-0.92) 
Tertiary 
education 
- 3, 951 1.00 - 3, 951 1.00 - 3, 951 1.00 
240 1, 086 1.13 (0.95-1.34) 128 1, 086 0.98 (0.78-1.22) 297 1, 086 1.66 (1.42-1.95) 
Do you have a TV in your house? 
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 Allergic Rhinitis Atopic Eczema Wheeze (Mahlati 2007) 
Exposure n N OR 
(95% CI) 
n N OR 
(95% CI) 
n N OR 
(95% CI) 
No 57 346 1.00 78 346 1.00 58 346 1.00 
How many people in your household are working? 
0 52 289 1.00 44 289 1.00 46 289 1.00 
1 313 1, 549 1.16 (0.82-1.64) 233 1, 549 1.01 (0.74-1.59) 282 1, 549 1.17 (0.83-1.69) 
2 364 1, 707 1.20 (0.85-1.69) 207 1, 707 0.87 (0.59-1.28) 388 1, 707 1.55 (1.10-2.22) 
3 128 598 1.18 ( 0.81-1.74) 88 598 1.06 (0.69-1.62) 129 598 1.45 (0.99-2.15) 
≥4 77 352 1.14 (0.75-1.73) 39 352 0.66 (0.40-1.08) 80 352 1.55 (1.02-2.37) 
How many people in your household are not working? 
0 354 1, 652 1.00 195 1, 652 1.00 408 1, 652 1.00 
1 315 1, 507 0.90 (0.75-1.09) 206 1, 507 1.11 (0.92-1.34) 282 1, 507 0.70 (0.58-0.83) 
2 137 724 0.87 (0.69-1.10) 129 724 1.51 (1.21-1.89) 114 724 0.56 (0.44-0.71) 
3 56 251 1.06 (0.75-1.50) 43 251 1.36 (0.97-1.90) 42 251 0.61 (0.42-0.87) 
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Table 5: Bivariate associations of allergic rhinitis, atopic eczema and wheeze symptoms with selected environmental exposures 
 Allergic Rhinitis Atopic Eczema Wheeze (Mahlati 2007) 
Exposure n N OR 
(95% CI) 
n N OR 
(95% CI) 
n N OR 
(95% CI) 
In your house, what fuel is usually used for cooking? 
Electricity - 599 1.00 - 599 1.00 - 599 1.00 
919 4, 436 0.90 (0.72-1.13) 585 4, 436 0.97 (0.74-1.26) 911 4, 432 1.10 (0.88-1.37) 
Gas - 4, 531 1.00 - 4, 531 1.00 - 4, 531 1.00 
129 503 1.51 (1.19-1.91) 80 503 1.27 (0.96-1.67) 96 502 0.91 (0.71-1.16) 
Paraffin  - 4, 145 1.00 - 4, 145 1.00 - 4, 145 1.00 
167 892 1.30 (1.06-1.60) 196 892 2.35 (1.91-2.90) 136 892 0.65 (0.53-0.80) 
Wood - 4, 954 1.00 - 4, 954 1.00 - 4, 954 1.00 
23 83 1.23 (0.74-2.06) 12 83 1.21 (0.61-2.39) 23 83 1.51 (0.88-2.49) 
In your house, what fuel is usually used for heating? 
Electricity - 1, 496 1.00 - 1, 496 1.00 - 1, 496 1.00 
770 3, 540 1.01 (0.86-1.20) 419 3, 540 0.64 (0.53-0.78) 753 3, 540 1.21 (1.03-1.42) 
Gas - 4, 806 1.00 - 4, 806 1.00 - 4, 806 1.00 
64 231 1.32 (0.96-1.81) 27 231 0.78 (0.54-1.15) 61 231 1.43 (1.04-1.94) 
Paraffin - 3, 856 1.00 - 3, 856 1.00 - 3, 856 1.00 
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 Allergic Rhinitis Atopic Eczema Wheeze (Mahlati 2007) 
Exposure n N OR 
(95% CI) 
n N OR 
(95% CI) 
n N OR 
(95% CI) 
Wood - 4, 733 1.00 - 4, 733 1.00 - 4, 733 1.00 
66 303 1.07 (0.79-1.44) 39 303 1.07 (0.73-1.56) 81 303 1.46 (1.11-1.91) 
Is your house damp or wet inside? 
Yes 118 507 1.32 (1.03-1.67) 106 507 1.78 (1.38-2.31) 93 507 0.85 (0.66-1.08) 
No 885 4, 305 1.00 536 4, 305 1.00 896 4, 305 1.00 
Do you have taps for running water in your house? 
Yes 821  3, 861 1.16 (0.95-1.39) 497 3, 861 0.95 (0.77-1.18) 836 3, 861 1.52 (1.25-1.86) 
No 324 933 1.00 205 933 1.00 143 933 1.00 
Do you have electricity in your house? 
Yes 981 4, 666 1.61 (1.02-2.53) 617 4, 666 0.97 (0.63-1.50) 964 4, 666 1.55  (1.01-2.46) 
No 51 181 1.00 34 181 1.00 26 181 1.00 
In the past 12 months, how often, on average, have you taken Panado? 
Never 221 1, 333 1.00 148 1, 333 1.00 214 1, 333 1.00 
At least 
once/year 
337 1, 764 1.14 (0.93-1.38) 232 1, 764 1.22 (0.97-1.55) 351 1, 764 1.29 (1.07-1.57) 
At least 
once/month 
452 1, 741 1.80 (1.48-2.18) 267 1, 741 1.43 (1.13-1.80) 434 1, 741 1.73 (1.44-2.09) 
Does your mother (or female care giver) smoke cigarettes? 
Yes 328 1, 405 1.07 (0.92-1.25) 145 1, 405 0.53 (0.43-0.65) 339 1, 405 1.34 (1.15-1.57) 
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Allergic Rhinitis Atopic Eczema Wheeze (Mahlati 2007) 
Exposure n N OR 
(95% CI) 
n N OR 
(95% CI) 
n N OR 
(95% CI) 
Do you smoke cigarettes? 
Yes 121 433 1.22 (0.96-1.54) 54 433 0.70 (0.51-0.96) 126 433 1.67 (1.33-2.10) 
No 888 4, 417 1.00 594 4, 417 1.00 868 4, 417 1.00 
Has anyone in your household ever had TB?
Yes 165 691 1.40 (1.13-1.72) 149 691 1.95 (1.55-2.45) 133 691 0.91 (0.74-1.12) 
No 839 4, 133 1.00 496 4, 133 1.00 854 4, 133 1.00 
Have you ever been treated for TB?
Yes 70 325 1.03 (0.77-1.38) 57 325 1.41 (1.01-1.97) 71 325 1.11 (0.83-1.46) 
No 920 4, 447 1.00 579 4, 447 1.00 893 4, 447 1.00 
What type of home do you have?
House 821 3, 936 1.00 470 3, 936 1.00 836 3, 936 1.00 
Flat 64 263 1.31 (0.95-1.80) 35 263 1.11 (0.75-1.66) 53 263 0.93 (0.67-1.28) 
Shack 107 573 1.18 (0.92-1.52) 135 573 2.43 (1.90-3.11) 86 573 0.65 (0.50-0.83) 
Other 12 60 0.74 (0.39-1.44) 7 60 0.90 (0.38-2.07) 12 60 0.92 (0.44-1.78) 
How many people share your bedroom at night? 
0 258 1, 201 1.00 137 1, 201 1.00 300 1, 201 1.00 
1 256 1, 285 0.86 (0.69-1.06) 168 1, 285 1.02 (0.78-1.32) 257 1, 285 0.75 (0.61-0.91) 
2 232 1, 078 0.91 (0.73-1.13) 161 1, 078 1.05 (0.81-1.38) 207 1, 078 0.71 (0.58-0.87) 










63 | P a g e  
 
 Allergic Rhinitis Atopic Eczema Wheeze (Mahlati 2007) 
Exposure n N OR 
(95% CI) 
n N OR 
(95% CI) 
n N OR 
(95% CI) 
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Table 6: Bivariate associations of allergic rhinitis, atopic eczema and wheeze symptoms with selected dietary exposures 
Allergic Rhinitis Atopic Eczema Wheeze (Mahlati 2007) 
Exposure n N OR 
(95% CI) 
n N OR 
(95% CI) 
n N OR 
(95% CI) 
Pulses (peas, beans) 
Never or 
rarely 




462 2, 274 1.06 (0.89-1.25) 297 2, 274 1.32 (1.06-1.63) 467 2, 274 0.89 (0.76-1.04) 
3 or more 
times a 
week 








537 2, 434 1.04 (0.87-1.24) 283 2, 434 0.69 (0.56-0.86) 557 2, 434 1.30 (1.00-1.50) 
3 or more 
times a 
week 
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Cereal (including bread) 
Never or 
rarely 




168 842 1.13 (0.83-1.54) 119 842 1.44 (1.00-2.08) 184 842 1.16 (0.86-1.56) 
3 or more 
times a 
week 








297 1, 651 0.79 (0.67-0.94) 231 1, 651 1.35 (1.09-1.66) 265 1, 651 0.50 (0.40-0.60) 
3 or more 
times a 
week 
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3.4 Comparison of multivariate associations of allergic rhinitis, eczema and 
wheeze symptoms  
Table 7 presents the findings of multivariate analyses. The findings for outcome of wheeze 
were based on the written (not video) questionnaire of the study by Mahlati (2007). 
Table 7: Summary of multivariate associations for the symptoms of allergic rhinitis, atopic eczema 
and wheeze 
 Allergic Rhinitis Atopic Eczema Wheeze (Mahlati 
2007) 







1.00 1.00 1.00 
English  1.43 (1.18 – 1.72) 1.85 (1.41 – 2.41) 1.8 (1.5 – 2.1) 
Xhosa  1.40 (1.13 – 1.73) 3.87 (2.97 – 5.05) 0.9 (0.7 – 1.1) 




1.12 (0.92 – 1.35) 0.96 (0.76 – 1.22) 
- 
TV in house (vs. no 
TV in house) 
1.19 (0.92 – 1.55) 0.87 (0.66 – 1.14) - 
Dietary factors (unless otherwise stated, reference is no or occasional exposure) 
Maize three or 
more times a week 
1.12 (0.91 – 1.37) 1.13 (0.90 – 1.43) 0.8 (0.6 – 1.0) 
Cereal three or 
more times a week 
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Allergic Rhinitis Atopic Eczema Wheeze (Mahlati 
2007) 
Risk factor OR (95% CI) OR (95% CI) OR (95% CI) 
Other environmental factors (unless otherwise stated, reference is no or occasional 
exposure) 
Paracetamol use at 
least once a month 
1.58 (1.35 – 1.84) 1.26 (1.04 – 1.53) 1.4 (1.2 – 1.6) 
House damp and 
wet inside (vs. not 
damp and wet) 
1.28 (0.99 – 1.65) 1.39 (1.05 – 1.84) 
- 
Household 
member with TB 
ever (vs. no TB 
ever in household) 
1.33 (1.07 – 1.66) 1.42 (1.12 – 1.82) - 
Respondent 
smoking  
1.31 (1.03 – 1.67) - 1.4 (1.1 – 1.8) 
Wood or open fires 
as cooking fuel (vs. 
other fuel sources) 
1.30 (0.77 – 2.21) - -
Some statistically significant associations that were observed in the bivariate analyses were
attenuated; others became statistically significant for another outcome during the stepwise
model-building.
Although both Xhosa and English had significant associations with both allergic rhinitis and 
atopic eczema, the former language of instruction was a stronger predictor for the outcome 
of eczema. Male gender was protective for both outcomes. Frequent paracetamol use (at 
least once a month) was a consistent finding for all allergic outcomes. Cereal consumption 
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A household member with TB was a predictor for both allergic outcomes. Exposure to wood 
or open fires as cooking fuel was not statistically significant for allergic rhinitis but had been 
found to be when all-cause rhinitis was the outcome (OR 2.00; 95% CI1.26 – 3.18). 
3.5 Multivariate associations of allergic rhinitis and atopic eczema (comorbid) 
symptoms  
The Online Repository contains the bivariate analyses for those adolescents with both 
allergic rhinitis and atopic eczema outcomes (comorbid).  
Table 8 showed that while Xhosa and English were significant risk factors. Consumption of
cereal and maize appear to be positively associated – although not statistically significant -
with comorbid symptoms. As expected, paracetamol use at least once a month was a
predictor. A household member with TB was positively associated with greater odds of
having both symptoms. In general, the associations were a combination of factors that
emerged from the individual conditions.
Table 8: Multivariate analysis: association of sociodemographic, dietary and environmental factors with
allergic rhinitis and atopic eczema (comorbid) symptoms
Risk factor OR 95% CI 
Sociodemographic factors 
Language of instruction at school: 









Male gender 0.39 0.30-0.53 
TV in house (vs. no TV in house) 0.75 0.50-1.11 
Dietary factors (unless otherwise stated, reference is no or occasional exposure) 
Cereal three or more times a week 1.16 0.86-1.56 
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3.6 The “commuter group” and influence on these allergic symptoms
Those adolescents who commuted from low SES areas to schools in higher SES areas
comprised a small proportion (1.7%) of the total population. The reference category was
those students from low SES areas but who attended schools in their low SES area (n=1,
912). 48.2% (41) of the “commuters” reported rhinitis symptoms in the past year compared
to 31.5% (603) of those students from the same low SES areas but attending local schools
within the area. The differences were less for eczema symptoms, namely; 24.7% (21) of
“commuters” and 25.9% (495) of those attending local schools. These prevalences were
more suggestive when the more specific definitions of the allergic outcomes were applied.
27.0% (23) of the “commuters” reported allergic rhinitis symptoms compared to 18.0% (345)
of those students from the same low SES areas but attending local schools within the area.
For atopic eczema symptom reporting there were 15.3% (13) of “commuters” and 19.7%
(376) of those attending local schools.









OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) 
Reference category: low SES 
areas to low SES schools 
1.00 1.00 1.00 1.00 
“Commuters”: low SES areas to 









Other environmental factors 
Paracetamol use at least once a month 1.45 1.11-1.89 
House damp and wet inside (vs. not damp and wet) 1.58 1.09-2.29 
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The “commuters” appear to be at an increased odds for rhinitis (all-cause and allergic). For 
the outcome of eczema, the findings are suggestive of a protective effect; although to a 
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IV. DISCUSSION
The ISAAC Phase Three data analyses of the allergic rhinitis and atopic eczema outcomes 
reveal the following notable findings.  
There were striking differences between allergic rhinitis and atopic eczema in the bivariate 
analyses as the predictors of allergic rhinitis – when assessed together with wheeze - 
suggest that, to a large extent, a higher social class (variables of language, maternal 
education and access to television) is a risk factor. The opposite was shown for atopic 
eczema, i.e., lower social class was found to be a predictor. 
When reviewed individually, the final models of allergic rhinitis and atopic eczema
demonstrate a mixture of biologic and class effects that are difficult to disentangle in such a
study design. The final model of associations of those with comorbid symptoms confirms this
statement.
This study found that there was a positive association between a primary school level of
education of the mother and the symptoms of allergic rhinitis in multivariate analyses. The
impact of parental education on health outcomes in children, especially those of an allergic
nature, is a variable that has generated interest. The historical effect of limited and unequal
access to education means that parental education can be used as a robust measure of
SES in South Africa. The use of this variable in another country may therefore have different
associations and implications. For example, Dom et al. (2009) have found that in Belgium,
children with at least one highly educated parent tend to be more atopic than children with
low-educated parents and that after adjustment for potential confounders, eczema in the
child was positively associated (almost double the odds) with a high educational level of the
parents.
The finding of this ISAAC analysis that maternal primary school level of education is a 
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condition of the house. The association between dampness and allergic rhinitis is discussed 
below.  
For both allergic rhinitis and atopic eczema, male gender was found to be protective in this 
study. There is limited research on gender reporting of allergic symptoms. MacLean et al. 
(2010) found that although societal expectations for behaviour which translates to symptom 
reporting exist for both sexes, boys reacted to them as “rules” while girls took them to be as 
“guidelines”. Therefore, while both felt pressurized to maintain composure in spite of physical 
or psychological symptoms, girls were more likely to consider seeking help if they were 
unwell than boys. Boys feared that their masculinity would be threatened were they to report 
any symptoms. Clough (2011) also links gender differences in disease to the hygiene 
hypothesis. Elements such as different societal norms of dressing (girls are more likely to be 
dressed in clothing that is not conducive for dirty play), cleanliness (the linking of dirt and 
immorality and standards for females “are generally higher”)  and parental supervision 
(parents are more likely to supervise the play of girls) could result in females being less 
exposed to microbial agents that stimulate the immune system, especially in a critical 
developmental period where the immune system may “benefit” the most from such 
exposure. The hormonal influences of oestrogen and progesterone may also be factors in 
the gender difference; they are noted to be immune-stimulatory while testosterone is anti-
inflammatory (Osman 2007). Lastly, environmental exposures such as cigarette smoking 
and exposure to cosmetics that usually have their experimental phases at adolescence may 
exacerbate these gender differences (Osman 2007). 
In the analysis of ISAAC Phase One data, Mercer et al. (2004) also reported that although 
the “commuters” (students resident in lower SES band attending schools in highest SES 
band) were a small sample (n=82 to 101), they had significantly higher prevalences of 
rhinitis and particularly eczema symptoms than the reference category (students resident in 
lower SES band attending schools in that same SES band). The previous findings as well as 










73 | P a g e A .  D e a r h a m
“in transition” to a higher SES at home, and hypothetically to a cleaner environment, and 
thus may be more prone to allergic disease. However, lack of statistical power limited the 
conclusions that could be drawn. 
In general, a clear picture of the effect of dietary exposures did not emerge for either
outcome. The literature review suggested seafood, cereal, starch and fruits as protective
factors (Ellwood 2001; Garcia-Marcos 2007). In this study, apart from cereal consumption,
neither seafood nor fruit consumption demonstrated any significant association with either
outcome. The multivariate analyses showed that only cereal intake 3 or more times a week
was a significant risk factor. Mahlati (2007) found maize consumption to be protective and
pasta consumption to be a risk factor for asthma symptom prevalence respectively. Pasta
and maize consumption were a risk factor and also protective for atopic eczema respectively 
but these findings did not persist in multivariate analyses.
In summary, an important limitation of the core written questionnaire for the dietary
component could be different cultural interpretations by the respondents. As with the range
of fast food available, cereal in the questionnaire may be interpreted as breakfast with
commercial brands (e.g. corn flakes) but could be only a slice of bread as well.
Damp housing was a risk factor for both outcomes. Batlles-Garrido et al. (2010) suggest that
dampness may be related to dust mite sensitization as well as allergens known as Alternaria
that proliferate in damp environments over time. Alternaria mould is present indoors and
outdoors and are among the largest spores (>10 µm); and therefore capable of inducing
allergic rhinitis as particles >10 µm are usually trapped in the upper airways 
(Randriamanantany 2010). The presence of Alternaria has been found to be an independent
risk factor for allergic rhinitis (Randriamanantany 2010) which may be consistent with the
dampness finding of this study.
Cooking with wood as a fuel was a risk factor for all-cause rhinitis but not statistically 










74 | P a g e    A .  D e a r h a m  
 
more of an irritant nature than cause of more specific allergic rhinitis. The combustion of 
biomass fuels such as wood for cooking and/or heating releases pollutants that include 
carbon monoxide (CO), volatile organic compounds (VOCs) and nitrogen dioxide (NO2). 
Acute and chronic respiratory health effects have been linked to these indoor pollutants. A 
study in Bangladesh (Khalequzzaman 2007) that measured the concentrations of certain 
pollutants found a significant association between the use of biomass fuels and respiratory 
symptoms such as nasal discharge (adjusted OR range 4.0 to 6.3). Eczema and asthma 
failed to show an association with these fuels. However, the authors recognized that the 
health impact of such indoor pollutants was far less than that of SES which would confound 
the results.  
More conclusive findings were from Padhi et al. (2008) – exposure to cooking smoke from 
biomass combustion was  significantly associated with the prevalence of doctor-diagnosed 
asthma (OR = 2.20; 95% CI 1.16-4.19) and other respiratory symptoms in children. This 
effect was independent of factors such as age, maternal education and household living 
conditions.  
Positive tuberculin reactivity has been found to be protective for allergic disease; either for 
both atopic eczema and rhinitis or either outcome (Shirakawa 1997; Steenhuis 2007; Miyake 
2007). The association between a household member with a history of TB and both allergic 
outcomes is inexplicable. The social class effects of environmental influences as well as the 
timing of the mycobacterial inhibition of atopy in life (Soysal 2008) are factors to consider in 
the role that TB plays in allergic disease. 
Lastly, paracetamol use at least once per month is a predictor of all three outcomes, 
including comorbid symptoms. There is biologic plausibility (Farquhar 2009) and the 
possibility of reverse causation may be less applicable as it was also a risk factor for the 
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However, Illi et al. (2004) showed a link between infantile atopic eczema and asthma (or
bronchial hyper responsiveness) that may persist to adolescence. An evaluation of cohort
data (Tapianinen 2010) found that adolescents with asthma or eczema at follow up had had
more febrile days per person-year at risk (PYR) in childhood than healthy adolescents.
Therefore, there may be an increased tendency for paracetamol administration amongst not
only children with diagnosed allergic disease, but also those who had symptoms but did not
consult a physician. Another prospective birth cohort (until 7 years of age) has shown a lack
of association between use of paracetamol for non-respiratory tract infections and asthma,
rhinitis and eczema outcomes (Lowe 2010). Since interventional study designs to address
this association have substantial resource and ethical implications, it may be more
appropriate to recognise that, despite the plausible biologic mechanisms, the benefits of
paracetamol administration in children as an anti-pyretic outweigh those of alternative
medications (e.g. non-steroidal anti-inflammatory) and its possible additional risk of allergic 
disease.
There are several limitations to consider in the interpretation of this study’s findings. Firstly,
interpretation of temporality associated with the cross-sectional study design is a limitation of
the study. As noted for the paracetamol variable in particular, reverse causation is difficult to
disprove in this type of design.
Whereas the use of a video questionnaire for asthma and wheeze reduced translation and 
cultural interpretation challenges in understanding these symptoms in the core written 
questionnaire, measurement bias was not able to be reduced for the rhinitis and eczema 
outcomes due to the lack of this component. 
The lack of allergy testing in this study has meant that an assessment of atopic status was 
dependent on additional questions in the core written questionnaire that, without the aid of a 
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V. CONCLUSION
The analyses demonstrate that in general, the outcomes of allergic rhinitis and wheeze
suggest findings in the same direction, i.e. of a positive socioeconomic gradient compared to
atopic eczema, which suggests a negative socioeconomic gradient. The positive
associations of high SES and allergic rhinitis lend support to the accepted understanding of
the hygiene hypothesis, i.e. with more sanitized surroundings there is a loss of protective
immune factors that were previously induced by exposure to microbial agents in food and
the environment. The second notable finding of the “commuter” group (low SES resident
students attending higher SES schools) and its increased odds of allergic rhinitis but
protected from atopic eczema compared to those adolescents from the same residence but
attending low SES schools, is also consistent with this hypothesis.
However, when each outcome is assessed on its own, a combination of high and low SES
associations is shown; this is confirmed by the findings of the comorbid group.
The contribution of diet requires more context-specific research as the interpretation of the
ISAAC questionnaire is very subjective.
The finding that male gender is protective for both allergic rhinitis and atopic eczema is
consistent with research that show for biologic and socially-engrained reasons, females may
be more likely to report general physical and psychological symptoms than males.
Lastly, even given the positive associations of paracetamol use at least once a month and all 
three allergic outcomes a study such as this cannot exclude reverse causation.  
This is the first analysis of the Cape Town ISAAC data that has compared the determinants 
of rhinitis, eczema and wheeze symptoms amongst adolescents. In conclusion, it is hoped 
that this study has contributed to a better understanding of the determinants of allergic 
rhinitis and atopic eczema symptoms, and their relation to those of wheeze, amongst 










77 | P a g e    A .  D e a r h a m  
 
REFERENCES  
Ait-Khaled, N., Pearce, N., Anderson, H.R., Ellwood, P., Montefort, S., Shah, J. and the 
ISAAC Phase Three Study Group. 2009, “Global map of the prevalence of symptoms of 
rhinoconjunctivitis in children: The International Study of Asthma and Allergies in Childhood 
(ISAAC) Phase Three” Allergy, vol. 64, pp.123–148. 
 
Annesi-Maesano, I., Oryszczyn, M.P., Raherison, C. Kopferschmittz, C., Pauliz, G., Taytard, 
A., Tunon de Lara, M., Vervloetz, D., Charpinw, D. 2004, “Increased prevalence of asthma 
and allied diseases among active adolescent tobacco smokers after controlling for passive 
smoking exposure. A cause for concern?” Clin Exp Allergy, vol. 34, pp. 1017–1023. 
 
Armentia, A., Banäuelos, C., Arranz, M.L., Del Villar, V., Martiân-Santos, J.M., Gil, F.J. M., 
Vega, J.M., Callejo, A., Paredes, C. 2001, “Early introduction of cereals into children's diets 
as a risk factor for grass pollen asthma” Clinical and Experimental Allergy, vol., 31, pp.1250 
– 1255. 
 
Asher, M.I. and Weiland, S.K on behalf of The Isaac Steering Committee. 1998, “The 
International Study of Asthma and Allergies in Childhood (ISAAC)” Clinical and Experimental 
Allergy, vol. 28, no. 5, pp. 52-66. 
 
Asher, M.I., Keil, U., Ross Anderson, H., Beasley, R., Crane, J., Martinez, F., Mitchell, E.A., 
Pearce, N., Sibbald, B., Stewart, A.W., Strachan, D., Weiland, S.K., William, H.C. 1995, 
“International study of asthma and allergies in childhood (ISAAC): rationale and methods” 
Eur Respir, vol. 8, pp 483–491. 
 
Asher, M.I., Montefort, S., Björkstén, B., Lai, C., Strachan, D., Weiland, S.K., William, H.C 










78 | P a g e A .  D e a r h a m
of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases 
One and Three repeat multicountry cross-sectional surveys” Lancet, vol. 368, pp. 733–43. 
Asher, M.I., Stewart, A.W., Mallol, J., Montefort, S., Lai, C., Aït-Khaled, N., Odhiambo, J.A., 
and the ISAAC Phase One Study Group. 2010, “Which population level environmental 
factors are associated with asthma, rhinoconjunctivitis and eczema? Review of the 
ecological analyses of ISAAC Phase One” Respiratory Research, vol. 11, no. 8.  
Batlles-Garridoa, J., Torres-Borregob, J., Rubı´-Ruiza, T., Bonillo-Peralesa, A., .Gonza´lez-
Jime´neza, Y., Mombla´n-DeCaboa, J., Aguirre-Rodrı´gueza, J., Losillas-Maldonadoa, A.,
Torres-Dazaa, M. 2010, “Prevalence and factors linked to allergic rhinitis in 10 and 11-year-
old children in Almerıa. Isaac Phase II, Spain” Allergol Immunopathol(Madr), vol. 38, no. 3,
pp.135–141.
Beasley, R.W., Clayton, T.O., Crane, J., Lai, C., Montefort, S., von Mutius, E., Stewart, A.
and the ISAAC Phase Three Study Group. 2010, “Acetaminophen Use and Risk of Asthma,
Rhinoconjunctivitis and Eczema in Adolescents: Isaac Phase Three”. Available:
doi:10.1164/rccm.201005-0757OC [Accessed 18 Jan. 2011].
Bergmann, R.L., Edenharter, G., Bergmann, K.E., Wahn, V., Forster, J., Zepp, F., Wahn, U. 
1998, “Atopic dermatitis in early infancy predicts allergic airway disease at 5 year” Clin Exp 
Allergy, vol. 28, pp. 965-70. 
Bjorksten, B., Clayton, T., Ellwood, P., Stewart, A., Strachan, D. and the ISAAC Phase III 










79 | P a g e A .  D e a r h a m
III of the International Study of Asthma and Allergies in Childhood” Pediatr Allergy Immunol, 
vol. 19, pp.110–124. 
Braback, L., Hjern, A., Rasmussen, F. 2005, “Social class in asthma and allergic rhinitis: a 
national cohort study over three decades” Eur Respir J, vol. 26, pp. 1064–1068. 
Brenninkmeijer, E. E. A., Schram, M.E., Leeflang, M. M. G., Bos, J. D., Spuls, P. I. 2008, 
“Diagnostic criteria for atopic dermatitis: as systematic review” British Journal of 
Dermatology, vol. 158, no. 4, pp. 754-765. 
Brunekeef, B., Stewart, A.W., Ross Anderson, H., Lai, C., Strachan, D., Pearce, N. And the
ISAAC Phase 3 Study Group. 2009, “Self-reported truck traffic on the street of residence and
symptoms of asthma and allergic disease: a global relationship in ISAAC Phase 3”
Environmental Health Perspectives, vol. 117, no.11, pp. 1791-1798.
Clough, S. 2011, “Gender and the hygiene hypothesis” Social Science & Medicine, vol. 72,
pp. 486 – 493.
Codispoti, C.D., Levin, L., LeMasters, G.K., Ryan, P., Reponen, T., Villareal, M., Burkle, J., 
Stanforth, S., Lockey, J.E., Khurana Hershey, G.K., Bernstein, D.I. 2010, “Breast-feeding, 
aeroallergen sensitization, and environmental exposures during infancy are determinants of 
childhood allergic rhinitis” J Allergy Clin Immunol, vol. 125, pp. 1054-60. 
Cohet, C., Cheng,S., MacDonald, C., Baker, M., Foliaki, S., Huntington, N., Douwes, J., 
Pearce, N. 2004, “Infections, medication use, and the prevalence of symptoms of asthma, 










80 | P a g e    A .  D e a r h a m  
 
 
Chalmers, D.A., Todd, G., Saxe, N., Milne, J.T., Tolosana, S., Ngcelwane, P. N., Hlaba, 
B.N., Mngomeni, L.N., Nonxuba, T. G., Williams, H. C. 2007, “Validation of the U.K. Working 
Party diagnostic criteria for atopic eczema in a Xhosa-speaking African population” British 
Journal of Dermatology, vol. 156, pp. 111–116. 
 
Chatzi, L., Kogevinas, M. 2009, “Prenatal and childhood Mediterranean diet and the 
development of asthma and allergies in children” Public Health Nutrition, vol. 12, no.9A, pp. 
1629–1634. 
 
Czarnobilska, E., Obtulowicz, K., Dyga, W., Spiewak, R. 2010. “A half of schoolchildren with 
‘ISAAC eczema’ are ill with allergic contact dermatitis”. Available: doi: 10.1111/j.1468-
3083.2010.03885.x [Accessed 17 Jan 2011]. 
 
Dom, S., Droste, J.H.J., Sariachvili, M.A., Hagendorens, M.M., Bridts, C.H., Stevens, W.J., 
Desager, K.N., Wieringa, M.H., Weyler, J.J. 2009, “The influence of parental educational 
level on the development of atopic sensitization, wheezing and eczema during the first year 
of life” Pediatr Allergy Immunol, vol. 20, pp. 438–447. 
 
du Prel, X., Krämer, U., Behrendt, H., Ring, J., Oppermann, H., Schikowski, T., Ranft, U. 
2006, “Preschool children's health and its association with parental education and individual 
living conditions in East and West Germany” BMC Public Health, vol. 6, pp. 312. Available: 
http://www.biomedcentral.com/1471-2458/6/312 [Accessed 29 March 2011] 
 
Ellwood, P., Asher, M.I., Bjorksten, B., Burr, M., Pearce, N., Robertson, C. F. and the ISAAC 










81 | P a g e A .  D e a r h a m
eczema symptom prevalence: an ecological analysis of the International Study of Asthma 
and Allergies in Childhood (ISAAC) data” Eur Respir J, vol. 17, pp. 436–443.  
Ellwood, P., Asher, M.I., Beasley, R., Clayton, T.O., Stewart, A.W. and the ISAAC Steering 
Committee. 2005, “The International Study of Asthma and Allergies in Childhood: Phase 
Three rationale and methods” Int J Tuberc Lung Dis, vol.  9, pp. 10-16.  
Eriksson, J., Ekerljung, L., Lotvall, J., Pullerits, T., Wennergren, G., Ronmark, E., Toren, K., 
Lundba, B. 2010, “Growing up on a farm leads to lifelong protection against allergic rhinitis” 
Allergy, vol. 65, pp. 1397–1403. 
Farquhar, H., Crane, J., Mitchell, E.A., Eyers, S., Beasley, R. 2009, Editorial “The
acetaminophen and asthma hypothesis 10 years on: A case to answer”J Allergy Clin
Immunol, vol. 124, pp. 649-51.
Flohr, C., Weinmayr, G., Weiland, S.K., Addo-Yobo, E., Annesi-Maesano, I., Bjorksten, B.,
Braback, B., Buchele, G., Chico, M., Cooper, P., Clausen, M., El Sharif, N., Martinez 
Gimeno, A., Mathur,R. S., von Mutius, E., Morales Suarez-Varela, M., Pearce, N., Svabe, V.,
Wong, G.W.K., Yu, M., Zhong, N.S., Williams, H.C. and the ISAAC Phase Two Study Group.
2009, How well do questionnaires perform compared with physical examination in detecting
flexural eczema? Findings from the International Study of Asthma and Allergies in Childhood
(ISAAC) Phase Two” British Journal of Dermatology, vol. 161, pp. 846–853.
Garcia-Marcos, L., Canflanca, I.M, Batlles Garrido, J., Lopez-Silvarrey Varela, A., Garcia-
Hernandez, G., Guillen Grima, F., Gonzalez-Diaz, C., Carvajal-Uruena, I., Arnedo-Pena, A., 
Busquets-Monge, R.M., Morales Suarez-Varela, M., Blanco-Quiros, A. 2007, “Relationship 
of asthma and rhinoconjunctivitis with obesity, exercise and Mediterranean diet in Spanish 










82 | P a g e    A .  D e a r h a m  
 
 
Graham, N. 2005, “The relationship between socio-economic deprivation and asthma 
prevalence and severity in Cape Town adolescents” Unpublished (BSc Honours research 
project, Department of Environmental and Geographic Sciences, University of Cape Town) 
 
Graham, N.M.H., Burrell, C.J., Douglas, R.M. 1990, “Adverse Effects of Aspirin, 
Acetaminophen, and Ibuprofen on Immune Function, Viral Shedding, and Clinical Status in 
Rhinovirus-Infected Volunteers” The Journal of Infectious Diseases, vol.162, pp. 1277-1282. 
 
Guler, N., Kirerleri, E., Ones, U., Tamay, Z., Salmayenli, N., Darendeliler, F. 2004, “Leptin: 
Does it have any role in childhood asthma?” J Allergy Clin Immunol, vol. 14, pp. 254-9. 
 
Haileamlak, A., Lewis, S.A., Britton, J., Venn, A.J., Woldemariam, D., Hubbard, R., Williams, 
H.C. 2005,  “Validation of the International Study of Asthma and Allergies in Children 
(ISAAC) and U.K. criteria for atopic eczema in Ethiopian children” British Journal of 
Dermatology, vol. 152, pp. 735–741. 
 
Haileamlak,  A., Dagoye, D., Williams, H., Venn, A.J., Hubbard, R., Britton, J., Lewis, S.A. 
2005, “Early life risk factors for atopic dermatitis in Ethiopian children” J Allergy Clin 
Immunol, vol. 115, no. 2, pp. 370-376. 
 
Hetland, J., Torsheim, T., Aarø, L.E. 2002, “Subjective health complaints in adolescence: 
dimensional structure and variation across gender and age” Scand J Public Health, vol. 30, 
pp. 223-230. 
 
Huang, S.L., Lin, K.C., Pan, W.H. 2001, “Dietary factors associated with physician-
diagnosed asthma and allergic rhinitis in teenagers: analyses of the first Nutrition and Health 










83 | P a g e A .  D e a r h a m
Ibargoyen-Roteta, N., Aguinaga-Ontoso, I., Fernandez-Benitez, M., Marin-Fernandez, B., 
Guillen-Grima, F., Serrano-Monzo, I., Hermoso-de-Mendoza, J., Brun-Sandiumetge, C., 
Ferrer-Nadal, A., Irujo-Andueza, A. 2007,  “Role of the Home Environment in 
Rhinoconjunctivitis and Eczema in Schoolchildren in Pamplona, Spain” J Investig Allergol 
Clin Immunol, vol. 17, no.3, pp. 137-144. 
Illi, S., von Mutius, E., Lau, S., Nickel, R., Gruber, C., Niggemann, B., Wahn, U and the 
Multicenter Allergy Study Group. 2004, “The natural course of atopic dermatitis from birth to 
age 7 years and the association with asthma” J Allergy Clin Immunol, vol. 113, pp. 925-31. 
ISAAC Steering Committee. 1993, “International Study of Asthma and Allergies in Childhood
Manual.” Auckland, New Zealand/Münster, Germany: ISAAC
Jones, C.M. 2001, “Invited Commentary: “Race,” Racism, and the Practice of Epidemiology”
Am J Epidemiol, vol. 154, no. 4, pp. 301-4.
Kajbaf, T.Z., Asar, S., Alipoor, M.R. 2011, “Relationship between obesity and asthma
symptoms among children in Ahvaz, Iran: a cross sectional study” Italian Journal of
Pediatrics, vol. 37, no.1. Available: doi:10.1186/1824-7288-37-1 [Accessed 17 Jan. 2011]
Khalequzzaman, M., Kamijima, M., Sakai, K., Chowdhury, N.A., Hamajima, N., Nakajima, T. 
2007, “Indoor air pollution and its impact on children under five years old in Bangladesh” 
Indoor Air, vol. 17, pp. 297–304. 
Lowe, A.J., Carlin, J.B., Bennett, C.M., Hosking, C.S., Allen, K.J., Robertson, C.F., Axelrad, 










84 | P a g e    A .  D e a r h a m  
 
asthma: prospective birth cohort study” BMJ, vol. 341:c4616. Available: 
doi:10.1136/bmj.c4616 [Accessed 15 March 2011]. 
 
 
MacLean, A., Sweeting, H., Hunt, K. 2010, “‘Rules’ for boys, ‘guidelines’ for girls: Gender 
differences in symptom reporting during childhood and adolescence” Social Science & 
Medicine, vol. 70, pp. 597–604. 
 
 
Mahlati, U. 2007, “Dietary and environmental factors associated with symptoms or diagnosis 
of asthma in Cape Town school children: Findings from the International Study of Asthma 
and Allergies in Childhood (ISAAC) Phase Three Study” Unpublished  (Thesis for MMed 
(Public Health), School of Public Health and Family Medicine, University of Cape Town) 
 
Mercer, M.J., Joubert, G., Ehrlich, R.I., Nelson, H., Poyser, M.A., Puterman, A., Weinberg, 
E.G. 2004, “Socioeconomic status and prevalence of allergic rhinitis and atopic eczema 
symptoms in young adolescents” Pediatr Allergy Immunol, vol. 15, pp. 234–241. 
 
Miyake, Y., Arakawaw, M., Tanaka, K., Sasaki, S., Ohya, Y. 2007, “Tuberculin reactivity and 
allergic disorders in schoolchildren, Okinawa, Japan” Clinical and Experimental Allergy, vol. 
38, pp. 486–492. 
 
Miyake, Y., Sasaki, S., Tanaka, K., Ohya, Y., Miyamoto, S., Matsunaga, I., Yoshida, T., 
Hirota, Y., Oda, H., and the Osaka Maternal and Child Health Study Group. 2007, “Fish and 
Fat Intake and Prevalence of Allergic Rhinitis in Japanese Females: the Osaka Maternal and 











85 | P a g e A .  D e a r h a m
Myer, L., Ehrlich, R.I., Susser, E.S. 2004, “Social Epidemiology in South Africa” Epidemiol 
Rev, vol. 26, pp. 112-123. 
Newson, R.B., Shaheen, S.O., Chinn, S., Burney, P.G.J. 2000, “Paracetamol sales and 
atopic disease in children and adults: an ecological analysis” Eur Respir J, vol. 16, pp. 817-
823. 
Nicolaou, N., Siddique, N., Custovic, A. 2005, “Allergic disease in urban and rural 
populations: increasing prevalence with increasing urbanization” Allergy, vol. 60, pp. 1357–
1360. 
Odhiambo, J.A., Williams, H.C., Clayton, T.O., Robertson, C.F., Asher, M.I. and the ISAAC
Phase Three Study Group. 2009, “Global variations in prevalence of eczema symptoms in
children from ISAAC Phase Three” J Allergy Clin Immunol, vol. 124, pp.1251-8.
Okada, H., Kuhn, C., Feillet, H., Bach, J.F. 2010, “The ‘hygiene hypothesis’ for autoimmune
and allergic diseases: an update” Clinical and Experimental Immunology, vol. 160, pp. 1–9.
Osman, M., Hansell, A.L., Simpson, C.R., Hollowell, J., Helms, P.J. 2007, “Gender-specific 
presentations for asthma, allergic rhinitis and eczema in primary care” Primary Care 
Respiratory Journal, vol. 16, no.1, pp. 28-35. 
Padhi, B.K. and Padhy, P.K. 2008, “Domestic Fuels, Indoor Air Pollution, and Children’s 










86 | P a g e    A .  D e a r h a m  
 
Poyser, M.A., Nelson, H., Ehrlich, R.I. 2002, “Socioeconomic deprivation and asthma 
prevalence and severity in young adolescents” Eur Respir J, vol. 19, pp. 892- 898. 
 
Pretoria: Statistics South Africa, 2005. “Census 2001: Primary tables Western Cape: Census 
’96 and 2001 compared”. Available: www.statssa.gov.za [Accessed 17 Jan 2011] 
 
Provincial Government of the Western Cape: Department of Health. 2010, “Annual 
Performance Plan 2010/11.” 
 
Prymula, R., Siegrist, C.A., Chlibek, R., Zemlickova, H., Vackova, M., Smetana, J., Lommel, 
P., Kaliskova, E., Borys, D., Schuerman, L. 2009, “Effect of prophylactic paracetamol 
administration at time of vaccination on febrile reactions and antibody responses in children: 
two open-label, randomised controlled trials” Lancet, vol. 374, pp. 1339–50. 
 
Quek, Y.W., Sun, H.L., Ng, Y.Y., Lee, H.S.,Yang, S.F., Ku, M.S., Lu, K.H., Sheu, J.N., Lue 
K.H. 2010, “Associations of serum leptin with atopic asthma and allergic rhinitis in children” 
Am J Rhinol Allergy, vol. 24, pp. 354–358.  
 
Randriamanantany, Z.A., Annesi-Maesano, I., Moreau, D., Raherison, C., Charpin, D., 
Kopferschmitt, C., Lavaud, F., Taytard, A., De Blay, F., Caillaud, D. 2010, “Alternaria 
sensitization and allergic rhinitis with or without asthma in the French Six Cities study” 
Allergy, vol. 65, pp. 368–375. 
 
Spergel, J.M., Paller, A.S. 2003, “Atopic dermatitis and the atopic march” J Allergy Clin 










87 | P a g e A .  D e a r h a m
Soysal, A., Bahceciler, N., Barlan, I., Bakir, M. 2008, “Lack of an inverse association 
between tuberculosis infection and atopy: By T-cell-based immune assay (RD1–ELISpot)” 
Pediatr Allergy Immunol, vol. 19, pp. 709–715. 
Steenhuis, T.J., van Aalderen, W.M.C., Bloksma, N., Nijkamp, F.P., van der Laag, J., van 
Loveren, H., Rijkers, G.T., Kuis, W., Hoekstra, M.O. 2007, “Bacille–Calmette–Guerin 
vaccination and the development of allergic disease in children: a randomized, prospective, 
single-blind study” Clinical and Experimental Allergy, vol. 38, pp. 79–85. 
Strachan, D.P., Sibbald, B., Weiland, S.K., Ait-Khaled, N., Anabwani, G., Anderson, H.R.,
Asher, M.I., Beasley, R., Bjorksten, B., Burr, M.L., Clayton, T., Crane, J., Ellwood, P., Keil,
U., Lai, C.K.W., Mallol, J., Martinez, F.D., Mitchell, F.A., Montefort, S., Pearce, N.,
Robertson, C.F., Shah, J.R., Stewart, A.W., von Mutius, F., Williams, H.C. 1997, “Worldwide
variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the
International Study of Asthma and Allergies in Childhood (ISAAC)” Pediatr Allergy Immunol,
vol. 8, pp.161-176.
Strachan, D.P., Cook, D.G. 1998, “Parental smoking and allergic sensitisation in children”
Thorax, vol. 53, pp.117–123.
Strina, A., Barreto, M.L., Cunha, S., de Oliveira, M., Moreira, S.C., Williams, H.C., 
Rodrigues, L.C. 2010, “Validation of epidemiological tools for eczema diagnosis in Brazilian 
children: the ISAAC’s and UK Working Party’s criteria” BMC Dermatology, vol. 10, no.11. 










88 | P a g e    A .  D e a r h a m  
 
Su, J.C., Kemp, A.S., Varigos, G.A., Nolan, T.M. 1997, “Atopic eczema: its impact on the 
family and financial cost” Archives of Disease in Childhood, vol. 76, pp. 159–162. 
 
Sweeting, H., West, P. 2003, “Sex differences in health at ages 11, 13 and 15” Social 
Science & Medicine, vol. 56, pp. 31–39. 
 
Tapiainen, T., Dunder, T., Mottonen, M., Pokka, T., Uhari, M. 2010. Letter to the Editor: 
“Adolescents with asthma or atopic eczema have more febrile days in early childhood: A 
possible explanation for the connection between paracetamol and asthma?” J Allergy Clin 
Immunol, vol., 125, no. 3, pp. 751-752.   
 
Torres-Borrego, J., Molina-Terán, A.B.  and Montes-Mendoza, C. 2008, “Prevalence and 
associated factors of allergic rhinitis and atopic dermatitis in children” Allergol Immunopathol, 
vol. 36, no. 2, pp. 90-100. 
 
Vlaskia, E., Stavricb, K., Isjanovskac, R., Seckovaa, L., M. Kimovskaa, M. 2006, “Overweight 
hypothesis in asthma and eczema in young adolescents”, Allergol et Immunopathol, vol. 34, 
no. 5, pp. 199-205. 
 
Weiland, S.K., von Mutius, E., Hüsing, A., Asher, M.I. on behalf of the ISAAC Steering 
Committee. 1999, “Intake of trans-fatty acids and prevalence of childhood asthma and 
allergies in Europe” The Lancet, vol. 353, pp. 2040-1.  
 
Weiland, S.K., Bjorksten, B., Brunekeef, B., Cookson, W.O.C., von Mutius, Strachan, D.P 










89 | P a g e A .  D e a r h a m
“Phase II of the International Study of Asthma and Allergies in Childhood (ISAAC II): 
rationale and methods” Eur Respir J, vol. 24, pp. 406–412. 
Wickens, K., Barry, D., Friezema, A., Rhodius, R., Bone, N., Purdie, G., Crane, J. 2005, 
“Fast foods – are they a risk factor for asthma?” Allergy, vol. 60, pp. 1537–1541. 
Williams, H., Robertson, C., Stewart, A., Ait-Khaled, N., Anabwani, G., Anderson, H.R.,
Asher, M.I., Beasley, R., Bjorksten, B., Burr, M.L., Clayton, T., Crane, J., Ellwood, P., Keil,
U., Lai, C.K.W., Mallol, J., Martinez, F.D., Mitchell, F.A., Montefort, S., Pearce, Shah, J.R.,
Sibbald, B., Strachan, D., von Mutius, F., Weiland, S.K.1999, “Worldwide variations in the
prevalence of symptoms of atopic eczema in the international study of asthma and allergies
in childhood” J Allergy Clin Immunol, vol. 103, pp.125-38.
Williams, H. and Flohr, C. 2006, “How epidemiology has challenged 3 prevailing concepts
about atopic dermatitis” J Allergy Clin Immunol, vol. 118, pp. 209-13.
Williams, H., Stewart, A., von Mutius, E., Cookson, H. Ross Anderson, H. and the
International Study of Asthma and Allergies in Childhood (ISAAC) Phase One and Three
Study Groups. 2008, “Is eczema really on the increase worldwide?” J Allergy Clin Immunol,
vol. 121, pp. 947-54.
Zar, H.J., Ehrlich, R.I., Workman, L., Weinberg, E.G. 2007, “The changing prevalence of 
asthma, allergic rhinitis and atopic eczema in African adolescents from 1995 to 2002” 











90 | P a g e A .  D e a r h a m
Appendix I 
Appendix 1A: Instructions for authors – Journal of Allergy and Clinical Immunology 
Official Journal of the American Academy of Allergy, Asthma and Immunology 
Editor in Chief DONALD Y. M. LEUNG, MD, PhD  
Managing Editor GEORGE WOODWARD  
Senior Journal Manager LAURA DINKINS-WHITE  
A. Original articles. These should describe fully, but as concisely as feasible, the results of
original clinical and/or laboratory research. The average Original article fills 7 pages in the
printed journal, although manuscripts that exceed this may be occasionally accepted for
publication at the Editors' discretion. In general, an Original article should not exceed 3500
words, not including the abstract, figure legends, and references. Abstracts should be 250
words or less. If possible, each figure legend should be held to 60 words or less. Each
Original article may be accompanied by no more than 8 graphic presentations (tables and/or
figures)— for example, 3 tables + 5 figures. (Additional text, tables, or figures can be
designated as "supplemental" material, which will be included in the JACI's Online
Repository. For more on this option, please see the "Online Repository Materials" section
below.) Please note: Original article manuscripts that are determined to significantly exceed
these limits may be returned to the authors for shortening prior to review. The manuscript
should be organized in the order listed below. Failure to follow this format may result in
the manuscript being returned to the author(s) for revision prior to review.
The title page, abstract, Capsule Summary, key words, abbreviations, text,
acknowledgments, references, tables and figure legends should be included in one word-
processing file (in .doc or .wpd format). Figures should be loaded as separate files in the
format specified below.
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have to your work's purpose and significance. Additionally, accurate indexing and 
abstracting of scientific articles depend on a clearly written title that conveys the key 
message of the paper. Thus, the title is the most important phrase in a paper and should 
inform and convince the potential reader that the article is important enough to read. Refer to 
the suggestions that follow to develop a title that is effective and appealing.  
• Keep the title simple, clear, specific, and succinct.
• Keep the title succinct: Limit it to 12 words or fewer.
• Aim for a title that can be quickly scanned and understood by the reader.
• Communicate a single subject or idea in the title.
• Construct the title around the article's key words.
• Picture the target audience and use terms and key words that are clear to and
familiar to that group.
• Eliminate all nonessential words and details; do not include information about
objectives and methods.
• Ask yourself these questions: Does the title capture/pinpoint what this paper is
about? Does it inform adequately?
• Include the specific symptom, condition, intervention, mechanism, or function of the
paper's central focus.
• Mention any defining population, age, gender, or animal species that distinguishes
the work.
• Use accurate English and correct, simple word order.
• Use terms that are specific rather than general (e.g., "penicillin" rather than 
"betalactam antibiotic") and include terms that clarify (e.g., "CXCR4" rather than 
"chemokine receptors").
• Avoid using strong words (such as "robust," "innovative," "significant," "vigorous," and 
"aggressive"), as they may suggest exaggerated or unwarranted claims.
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universally understood pun can work well to attract interest, ensure that it will not 
confuse or mislead the reader.  
• Finalize the title after completing the manuscript: review the title after any revisions to 
ensure that it still communicates the paper's core message.  
 
The title should be followed by: 
• The list of authors, including their full names, highest academic degrees, and 
institutional affiliations. Restrict the list of authors to those who have made material 
contributions to the research and who contributed to the writing and review of the 
manuscript.  
• The name, address, telephone number, fax number, and e-mail address of the author 
who should be contacted regarding reprint requests or other correspondence 
received in the Editorial Office regarding the manuscript.  
• A declaration of all sources of funding. Authors are required to disclose any financial 
relationship with a biotechnology and/or pharmaceutical manufacturer that has an 
interest in the subject matter or materials discussed in the submitted manuscript.  
• A total word count, which includes the number of words in the body of the manuscript 
(Introduction through Discussion only); the abstract should not be included in the 
count. Figure and table legends are included in the estimation of the overall space 
required for figures and tables, so they should not be counted here.  
 
2. Abstract. As a general rule, the abstract should be no longer than 250 words. It should 
summarize the results and conclusions concisely. Tabular data should not be included and 
acronyms/abbreviations should be avoided or spelled out fully. Abstracts should be 










93 | P a g e A .  D e a r h a m
• Background: What is the major problem that prompted the study?
• Objective: What is the purpose of the study?
• Methods: How was the study done?
• Results: What are the most important findings?
• Conclusion: What is the most important conclusion drawn?
3. Clinical Implications or Key Messages. Provide ONE of the following:
either 
• a very brief paragraph (consisting of no more than 30 words) summarizing the diagnostic,
therapeutic, or management implications of the article. 
The heading for this paragraph should be Clinical Implications.
or 
• (if the article is mechanistic) two or three independent bulleted statements that present the
key findings or concepts in the article and perhaps comment on their implications. The
heading for this small set of bulleted statements should be Key Messages.
4. Capsule summary. The Table of Contents entry for each Original Article published in the
Journal includes a short summary that encapsulates the report's findings for a clinically 
oriented audience. To create this summary, the authors must compose one or two brief 
sentences (totaling no more than 35 words) that describe the article's contribution to the 
literature. These sentences should succinctly state why the article is important and 
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5. Key words. A list of up to ten key words should follow the Capsule Summary. 
 
6. Abbreviations. Provide a list of any abbreviations/acronyms (and their definitions) on a 
separate page following the key words. Only standard abbreviations are to be used. Consult 
Scientific Style and Format by the Council of Biology Editors or the AMA's Manual of Style. A 
laboratory or chemical term or the name of a disease process that will be abbreviated must 
be spelled out at first mention, the acronym or abbreviation following in parentheses. 
 
Please note: Abbreviations in the title and abstract are not acceptable. Even if they are 
included in the list of abbreviations, they should be spelled out in those locations. 
 
7. Text. The manuscript should be written in clear and concise English. Authors whose 
primary language is not English should obtain assistance with writing to avoid grammatical 
problems. The text should be organized in sections as follows: Introduction, Methods, 
Results, and Discussion. Each section should begin on a new page.  
The generic terms for all drugs and chemicals should be used.
 
In studies involving human subjects, a statement describing approval by the appropriate 
Institutional Review Board is required. Studies involving experimental animals must include a 
statement in the Methods section indicating which guidelines were followed for the care and 
use of the animals (e.g., the "Principles of Laboratory Animal Care" formulated by the 
National Society for Medical Research or the "Guide for the Care and Use of Laboratory 
Animals" prepared by the Institute of Laboratory Animal Resources, National Research 
Council, and published by the National Academy Press [revised 1996]).
 
8. Acknowledgments. General acknowledgments for consultations, statistical analyses, and 
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However, acknowledgment of funding should be listed on the title page.
 
9. References. It is the Editors' expectation that authors will perform a comprehensive 
search of the literature to gather the most current articles relative to the subject matter. All 
references that are five years old or more should be replaced with current literature, unless 
the referenced publication is a classic work that underscores the core subject. 
 
References should follow "Vancouver style."  
See http://www.nlm.nih.gov/bsd/uniform_requirements.html for more information. 
Manuscripts in preparation, personal communications, and other unpublished information 
should not be cited in the reference list but may be mentioned in the text in parentheses. The 
references must be identified in the text by superscript Arabic numerals and numbered in 
consecutive order as they are mentioned in the text. The list of references, in numeric 
sequence, should be typed at the end of the article. Typing of the references is preferred 
over the use of your word processing program's footnote or endnote feature (or a program 
such as EndNote or Reference Manager) to create citations. If you do use EndNote, please 
remove the links between the reference number and the citations by taking the following 
steps: (1) Using the "Select All" feature (Ctrl-A for PCs. Cmd-A for MACs), highlight the 
entire text of the file, including the references. (2) Use the keystroke command "Ctrl-6" for
PCs of "Cmd-6" for MACs. (3) Save.  
This will remove the links (permanently) without disturbing the reference numbers or the 
citations. It is recommended that you save one copy of your manuscript with the EndNote 
links in place (for your reference) and one copy of your manuscript without the EndNote links 
(for submission purposes). 
 
Please note that inclusive page numbers are required. List all authors' names when there 
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Formatting of Articles  
Basic Formatting  
Be sure the entire manuscript (all text, legends, captions, etc.) is in a standard font such as 
Times New Roman, Arial, or Courier, size 12. All sections, including references, should be 
double-spaced, with margins of at least one inch on all sides. On each page, the last name 
of the first author and the page number should appear in the upper right corner. Begin 
numbering with the title page as page 1. Be sure to display line numbers (1, 2, 3, and so 
forth) in the left margin of the manuscript. (Line numbering can be added from the Page 
Setup or Format menu of word processing programs.) The line numbering should be 
continuous throughout the entire manuscript, from the title page through final page (i.e., do 
not begin numbering from 1 again at the top of each page). 
Graphic Presentations
The total number of graphic presentations (tables and/or figures) per manuscript should be
no greater than 8 (examples: 8 tables + 0 figures; 5 tables + 3 figures; 2 tables + 6 figures; 0
tables + 8 figures).
A. Tables. If tables appear in the manuscript, they must be included in the electronic
submission. They may be placed within the manuscript file or loaded as separate files (in 
.doc or .wpd format). Tables should supplement, not duplicate, the text; they should be on 
separate pages, one table per page, and should be self-explanatory and numbered with 
Roman numerals in order of mention. A brief title should be provided directly above each 
table. Any text within the table should be in Times New Roman font. Any abbreviations 
should be defined at the bottom of the table. When creating a table, use the word-processing 
program's table formatting feature; otherwise, use only tabs (not spaces) to align columns. 










97 | P a g e    A .  D e a r h a m  
 
number should appear in the electronic file. The maximum size for a table is ½ page. The 
maximum number of graphic presentations (tables and/or figures) per manuscript is 8 
(examples: 8 tables + 0 figures; 5 tables + 3 figures; 2 tables + 6 figures; 0 tables + 8 
figures). 
 
B. Figure legends. Figure legends should be typewritten, double-spaced, and listed on a 
separate page after the tables. They should not appear on the figures. The figure legend will 
be included when sizing the figure and its length must therefore be taken into consideration. 
The figure title should appear at the beginning of each legend. The legends themselves 
should be succinct (no more than 60 words), identifying the data or subject being presented, 
but explaining methods or results. Do not place titles or legends within the figures. 
 
C. Figures. If illustrations appear in the manuscript, they must be submitted in electronic 
format along with the rest of the manuscript. Each figure should be submitted as a separate 
electronic file, and should not be inserted into the file containing the text of the manuscript. 
Complete instructions for online submission are available in the "Tutorial for Authors" at the 
EES Web site http://ees.elsevier.com/jaci/). The maximum number of graphic 
presentations (tables and/or figures) per manuscript is 8 (examples: 8 figures + 0 tables; 6 
figures + 2 tables; 3 figures + 5 tables; 0 figures + 8 tables). 
 
Online Repository Materials  
The Journal will consider posting ancillary materials (non-essential tables, figures, 
appendices, questionnaires, etc.) in an Online Repository (OR) on the JACI Web site (  
http://www.jacionline.org). The OR is for peer-reviewed material that cannot be included in 
the print version of an article due to space considerations. The Editor and reviewers are able 
to review material proposed for the OR. Readers of the Journal's print version will be 
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directly into the downloadable PDF of the manuscript.
On an individual basis, the Editors will determine whether ancillary material submitted in
support of a manuscript is warranted. In some instances, an Editor may suggest when
requesting a revision that part of the data be presented for the OR and removed from the
manuscript, perhaps at the request of the reviewers. In both cases, authors should include a
cover letter to the Editor, indicating the material to be considered for the OR and justifying its
inclusion.
The ancillary material must be submitted in EES simultaneously with the rest of the
manuscript. The OR material should be loaded as separate files, and should follow the end
of the regular manuscript. For revisions that will include newly designated OR material, the
Marked Manuscript should show where materials were removed from the original version,
and include appropriate statements directing readers of the article in the print journal to the
OR. The Unmarked Manuscript will reflect the latter changes. For more complete
instructions, see the "Tutorial for Authors" at the EES Web site (
http://ees.elsevier.com/jaci/).
Online Repository materials must be accompanied by a separate title page that includes the
heading "Online Repository," all author names and their affiliations, and contact information
for the corresponding author. All text files for the OR should be formatted per directions for
regular manuscript materials (see section A). Tables for the OR should be submitted as files 
with any of the following extensions: .pdf, .csv, .txt, .doc, .rtf, .xls, .ppt. Figures for the OR do
not need to conform to the print specifications for resolution, but they do need to appear
clear and crisp when viewed electronically. PowerPoint files may be used. Figures and
Tables must be labeled with unique designations as Figure E1, Table E1, etc. Similarly, if
citations are made within the ancillary material, a list of references, separate from the
manuscript's references, must be included and labeled E1, E2, etc. Authors may repeat
sentences or references in the OR that are included in the manuscript, if necessary for
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Repository must be referenced specifically ("see Figure E1 in the Online Repository"). It is 
important to remember that material for the OR is independent from the manuscript and will  
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Appendix 1B: Ethics approval letter 
UNIVERSiTY OF CAPE TOWN 
01 August 2001 
REF REC: 203/2001 
Dr H. Zar 
Paediatrics 
Dear Dr Zar 
Research Ethics Committee 
F acuity of Health Science 
Anzio Road, Observatory , 7925 
Queries : Xolile Fula 
Tel : (021) 406-6492 Fax: 406-6390 
E-mail : Xfula@curie.ucl.ac.za 
THE INTERNATIONAL STUDY OF ASTHMA AND ALLERGIES IN 
CHILDHOOD (ISAACO PHASE THREE IN CAPE TOWN, SOUTH AFRICA 
Thank you for submitting your study to the Research Eth ics Committee for 
review. 
It is a pleasure to inform you that the Committee has formally approved your 
study. 
Please quote the above REC reference number in a/l correspondence 
Attached is a copy of the list of members who attended the meeting. 
/) 
Yours sincerely/ ~fi'd 'I . h . ,/ 
I . \ I." . <. / /(;'(.// L/ " l&,-,-, /. . 
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Appendix 1C: Consent form for parents 
Dear Parent/Guardian 
We are inviting your child to take part in an important survey about child health with the 
approval of your school.  First, your child will be asked to complete a questionnaire on 
breathing, nose and skin problems.  Then a 7 minute video about exercise and breathing will 
be shown and your child will be asked to complete a further questionnaire.  The survey will 
take up to 40 minutes of class time, and will be done during a suitable class period. 
This survey is being carried out in randomly selected schools in Cape Town and also in 
many overseas countries including Australia, Canada, USA, Britain, Kenya and Germany. 
We ask you to consider this information sheet, and if you agree to your child taking part in
the survey, then please sign below. Your child's questionnaire will be treated confidentially,
only a code number will be entered in the computer.
This survey has the approval of your child's Principal and teachers. It also has the approval
of the University of Cape Town's Ethics and Research Committee and the Department of
Education and Culture.
If there is any further information you require about the survey, please contact me at
telephone: 685-4103.
Yours sincerely 
Dr Heather Zar 
Principal Investigator 
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Please return this section to school with your child:
I agree to allow my child to take part in a survey on breathing, nose and skin problems. 
Signed . . . . . . . . . . . . . . . . . . . . . . . .  Parent's Name: . . . . . . . . . . .  . . . . . . . 
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Appendix 1D: Consent form for children 
CONSENT FORM FOR CHILDREN AGED 13 TO 14 YEARS: Cape Town Survey of 
Breathing, Nose and Skin Problems in Children:  Phase Three 
We are inviting you and the other children in your class to take part in an important study to 
understand more about the increasing problem of breathing, nose and skin problems in 
children.  Many schools in Cape Town took part in a similar study in 1995, and your school 
has been selected to participate in this study.  This study is being carried out in a number of 
schools in Cape Town and in many overseas countries. 
 
We will ask you to complete a written questionnaire and to watch a video about exercise and 
breathing which lasts about ten minutes.  The survey will take about 60 minutes and will be 
done during a school period. This study has been approved by the Ethics Committee of the 
University of Cape Town. If you have questions or require further information about the 
study, you can discuss these with a member of our research team when they visit your 
school. You may choose not to participate if you do not want to. 
 
Thank you. 
Dr Heather Zar 
Principal Investigator 
------------------------------------------------------------------------------------------------------------ 
I, __________________________________(name) agree to participate in the survey on 
respiratory and skin problems in children. 
 
Signed: __________________________ 
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Appendix 1E: Questionnaire (English version) 
SURVEY OF BREATHING, NOSE AND SKIN PROBLEMS 
                                     
Office Use Only 
         
 
V. Instructions for completing the questionnaire 
On this sheet are questions about your name, address, and birth date. Please write in your 
answers to these questions in the space provided. 
All other questions require you to TICK your answer in a box or WRITE the answer in a box. 
If you make a mistake put a cross in the box and tick the correct answer. Only mark one 
option. 
 




 Yes No 
To answer Yes/No, put a tick in the 
appropriate box as per example 
 
 
Your name:     
 
 
School:      
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Your date of birth: 
 Day  Month  Year 
 





Were you born in Cape Town?     Yes  No 
 
If you were not born in Cape Town,  
how old were you when you came to Cape Town? Years 
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 Yes        No 
1. Have you ever had wheezing or whistling in the chest  
 at any time in the past? 
   
     
1. IF YOU HAVE ANSWERED “NO” PLEASE SKIP TO QUESTION 6 
 
 
 Yes       No 
2. Have you had wheezing or whistling in  
 the chest in the past 12 months? 
   
 
IF YOU HAVE ANSWERED “NO” PLEASE SKIP TO QUESTION 6 
 
3. How many attacks of wheezing have  
 you had in the past 12 months? 
 





        
 
4. In the past 12 months, how often, on average, has 











         
 
  Yes        No 
5. In the past 12 months, has wheezing ever been severe enough  
 to limit your speech to only one or two words at a time between 
 breaths? 
   
   
  Yes        No 
6. Have you ever had asthma? 
 
   
 
 
  Yes        No 
7. In the past 12 months, has your chest sounded wheezy 
 During or after exercise? 
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  Yes        No 
8. In the past 12 months, have you had a dry cough at night,  
 Apart from a cough associated with a cold or chest infection? 
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ALL QUESTIONS ARE ABOUT PROBLEMS THAT OCCUR WHEN YOU DO NOT HAVE 
A COLD OR THE FLU  
  Yes        No 
9. Have you ever had a problem with sneezing, or a runny, or blocked nose 
when you DID NOT have a cold or the flu? 
   
 
IF YOU HAVE ANSWERED “NO” PLEASE SKIP TO QUESTION 14 
  Yes        No 
10. In the past 12 months, have you had a problem with sneezing, or a runny, 
or blocked nose when you DID NOT have a cold or the flu? 
   
 
IF YOU HAVE ANSWERED “NO” PLEASE SKIP TO QUESTION 14 
 
  Yes        No 
11. In the past 12 months, has this nose problem been accompanied by  
 Itchy-watery eyes? 
   
 
 
12. In which of the past 12 months  
 Did this nose problem occur? 
 (Please tick any which apply) 
January February March April 
            
May June July August 
            
September October November December 
            
 
 
13. In the past 12 months, how much  
 did this nose problem interfere  
 With your daily activities? Not at 
all 




         
 
 
  Yes        No 
14. Have you ever had hayfever? 
 










108 | P a g e    A .  D e a r h a m  
 
  Yes        No 
15. Have you ever had an itchy rash which was coming  
 And going for at least six months? 
   
 
2. IF YOU HAVE ANSWERED “NO” PLEASE SKIP TO QUESTION 20 
 
 
  Yes        No 
16. Have you had this itchy rash at any time in the past 12 months? 
 
   
 
3. IF YOU HAVE ANSWERED “NO” PLEASE SKIP TO QUESTION 20 
 
 
  Yes        No 
17. Has this itchy rash at any time affected any of the following places: 
  
   
the folds of the elbows, behind the knees, 
in front of the ankles, under the buttocks, 
or around the neck, ears or eyes? 
 
  Yes        No 
18. Has this rash cleared completely at any time 
 during the past 12 months? 
   
 
  
19. In the past 12 months, how often, on average,  
 have you been kept awake at night by  
 this itchy rash? 
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  Yes        No 
20. Have you ever had eczema? 
 








1. Weight:  kg  
 
2. Height:  centimetres  
 
3. In the past 12 months, how often, on average, did you eat or drink the following?:  
 (Please leave blank if you do not know what the food is)  
Never or 
rarely 
Once or twice 
per week 
Three or 
more times a 
week 
 Meat (e.g. beef, lamb, chicken, pork)        
       
 Seafood (including fish)       
       
 Fruit       
       
 Vegetables (all types)        
       
 Peas, beans        
       
 Cereal (including bread)        
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 Pasta        
       
 Rice       
       
 Butter        
       
 Margarine        
       
 Nuts (including Peanuts)       
       
 Potatoes        
       
 Milk        
       
 Eggs        
       
 Fast food/burgers       
 
 
4. How many times a week do you have enough exercise or physical effort to make you 
breathe hard?:  
  Never or occasionally   
   
 Once or twice per week   
   
 Three or more times a week   
 
5. During a normal week, how many hours a day do you watch television?: 
  Less than 1 hour   
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 1 hour but less than 3 hours   
   
 3 hours but less than 5 hours   
   
 5 hours or more   
 
6. In your house, what fuel is usually used for cooking?: 
  Electricity   
   
 Gas   
   
 Paraffin   
   
 Wood (including open fires)   
   
 Other - Please specify   
 
7. In your house, what fuel is usually used for heating?: 
  Electricity   
   
 Gas   
   
 Paraffin   
   
 Wood (including open fires)   
   
 Other - Please specify   
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  Never    
   
 At least once a year   
   
 At least once per month   
 
9. How many older brothers and sisters  
 do you have?: 
 brothers and sisters 
 
10. How many younger brothers and  
 sisters do you have?: 
 brothers and sisters 
 
11. Were you born in South Africa?: 
 
  Yes   
   
 No   
 
12. How many years have you lived in South Africa?:  years 
 
13. What level of education has your mother reached or completed?:  
 
  Primary school   
   
 High school   
   
 College, university or other form of tertiary education   
 
14. What level of education has your father reached or completed?: 
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 High school   
   





15. How often do trucks pass along the street where you live, on weekdays? 
 
  Never   
   
 Seldom   
   
 Frequently through the day   
   
 
16. In the past 12 months, have you had a cat in your home?: 
  Yes   
   
 No   
 
17. In the past 12 months, have you had a dog in your home? 
  Yes   
   
 No   
 
18. Does your mother (or female care giver) smoke cigarettes?: 
  Yes   
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19. Does your father (or male care giver) smoke cigarettes?: 
  Yes   
   
 No   
 
20. How many people living in your house smoke cigarettes?:  people 
 
21. Do you smoke cigarettes?: 
  Yes   
   







22. Is your house damp or wet inside?: 
  Yes   
   
 No   
 
23. Has anyone in your household ever had TB?: 
  Yes   
   
 No   
 
24. Have you ever been treated for TB?:   
  Yes   
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 No   
 
25. How many people live in your house?: 
  Adults   
   
 Children   
   
 
26. Do you have taps for running water in your house?: 
  Yes   
   
 No   
 
27. Do you have electricity in your house?: 
  Yes   
   
 No   
 
28. Do you have a TV in your house?: 
  Yes   
   







29. What type of home do you have?: 
 House     
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 Flat    
    
 Shack    
    
 Other    
    
 
 
30. How many people living in your household have regular jobs?:  people 
 
31. How many people living in your household are unemployed and 
looking for work?: 
 people 
 





PLEASE WAIT FOR THE VIDEO TO START BEFORE COMPLETING THE NEXT 
SECTION OF THE QUESTIONNAIRE. 
 
 Yes  No 
1. Has your breathing been like this at any time in your life?    
    
If YES, has this happened in the last year?    
    
If YES, has this happened one or more times a month?    
 
 
 Yes  No 
2. Has your breathing been like the boy’s in the dark shirt following exercise 
at any  time in your life? 
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If YES, has this happened in the last year?    
    
If YES, has this happened one or more times a month?    
 
 
 Yes  No 
3. Have you been woken like this at night, at any time in your life?    
    
If YES, has this happened in the last year?    
    
If YES, has this happened one or more times a month?    
 
 
 Yes  No 
4. Have you been woken at night like this, at any tim  in your life?    
    
If YES, has this happened in the last year?    
    
If YES, has this happened one or more times a month?    
 
 
 Yes  No 
5. Has your breathing been like this, at any time in your life?    
    
If YES, has this happened in the last year?    
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Appendix 1F: Questionnaire (Xhosa version) 
 
Uphando lweengxaki zokuphefumla, impumlo nolusu 
                                     
Isetyenziswa yi-ofisi kuphela          
 
VI. Imiyalelo yokuphendula imibuzo wkiphepha lemibuzo 
Kweli phepha yimibuzo malunga negama lakho, Idilesi yasekhaya, umhla wokuzalwa. Nceda bhala 
iimpendulo zale mibuzo kwisikhewu esinikiweyo. 
Yonke eminye imibuzo ifuna uphawule impendulo yakho okanye ubhale kwi bhokisi. Xa wenze 
impazamo Hlaba kwibhokisi uze ufake uphawu olulungileyo kwimpendulo echanekileyo kuwe. 
 
Imizekelo yokuphawula impendulo :               Iminyaka 
 Iminyaka 
 
      Ewe           Hayi  




Igama lakho:     
 
 
Isikolo Sakho:      
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 Umhla Inyanga  Unyaka 
 





Wazalelwa e-Kapa?  Ewe                  Hayi 
 
Ukuba akuzalwanga e-Kapa ufike uminyaka, mingaphi  
E-Kapa ? Yeminyaka 
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                                                                                               Ewe      Hayi 
1. Wakha wanaso isifuba esishinyeneyo okanye esiminxeneyo nanini na 
ngaphambili? 
   
     
4. Ukuba uphendule “hayi” nceda tsibela kumbuzo 6 
 
 
                                                                                                                      Ewe        Hayi 
2.  Wakha wanaso isifuba esishinyeneyo  kwezi nyanga zili-12 zigqithileyo?    
 
Ukuba uphendule “hayi” nceda tsibela kumbuzo 6 
 
3.  Uhlaselwe kangaphi kwezi nyanga zili-12 zigqithileyo sisifuba esishinyeneyo? 
 Zange  1 kuye 
3 




        
 













         
                                                                                                                          Ewe Hayi 
5. Kwiinyanga ezili-12 ezigqithileyo,Kwakha kwanzima ukutswina kwesifuba 
kangangokuba kunqumle ukuthetha kwakho de ubize igama libe linye ngexesha 
uzama ukuphefumla? 
   
   
                                                                                                                         Ewe  Hayi 
6. Wakha wanayo I-athsma? 
 
   
 
 
             Ewe      Hayi 
7. Kwiinyanga ezili-12, ezigqithileyo sakha isifuba sakho savakala sishinyene 
siminxene ngethuba okanye emva komthambo? 
   
 
              Ewe       Hayi 
8.  Kwiinyanga ezi –12 ezigqithileyo wakha wanalo okhohlokhohlo olomileyo 
ebusuku,  
Ingelulo olomkhuhlane okanye ulosuleleko lwesifuba? 












121 | P a g e    A .  D e a r h a m  
 
    Yonke imibuzo ibhekiselele xa ungenayo ingqele okanye I-flu         Ewe    Hayi                                                       
9. Wakha wanayo  ingxaki yokuthimla okanye impumlo evuzayo kodwa  Ungenayo I-
flu  okanye ingqele? 
   
 
Ukuba uphendule “hayi” Nceda tsibela kumbuzo 14 
  
                                                                                                                          Ewe  Hayi 
10. Kwezi nyanga zili-12 zigqithileyo, wakha wanengxaki yokuthimla  okanye 
impumlo evuzayo enemfuxane kodwa Ungenayo I-flu okanye ingqele? 
   
 
Ukuba uphendule “hayi” nceda tsibela kumbuzo 14 
 
 Ewe Hayi 
11.Kwiinyanga ezili-12, ezigqithileyo, yakha le ngxaki yempumlo yakhatshwa 
ngamehlo arawuzelayo alilayo/ aneenyembezi? 
   
 
 
12. Yenzeka kuyiphi kwezi  nyanga zili-12 
zigqithileyo le ngxaki yeempumlo  
(Nceda phawula  nayiphi elungileyo) 
Januari Februari Matshi Apreli 
            
Meyi Juni Julayi Agasti 
            
Septemba Oktoba Novemba Decemba 
            
 
 
13. Kwiinynga ezili-12 ezigqithileyo, 
Ikuphazamise kangakanani le ngxaki 





 Ngokuphakathi nje Kakhu
lu 
 




             Ewe       Hayi 
14. Wakha wanayo I-hayfever? 
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         Ewe     Hayi 
15. Wakha wanayo irashalala erawuzelayo emana ifika iphinde iphele ubuncinane 
iinyanga ezintandathu ? 
  
   
 
5. Ukuba uphendule “hayi” nceda tsibela kumbuzo 20 
 
 
        Ewe       Hayi 
16. Ukhe wanayo le arshalala irawuzelayo Nanini na kwezi nyanga zili –12 
zigqithileyo? 
 
   
 
6. Ukuba uphendule “hayi” nceda Tsibela kumbuzo 20 
 
 
        Ewe    Hayi 
17. Yakha le rashalala irawuzelayo nanini na yakwezindawo zilandelayo?: 
  
   
Kwimiphakathi yeengqiniba, emva kwamadolo, ngaphambi  kwezihlahla, ezantsi kweempundu, 
okanye irangqe intamo, iindlebe, namehlo? 
 
 
       Ewe       Hayi 
18. Yakha yaphela tu le rashalala kwesi sithuba seenyanga ezili 12 
Zidlulileyo? 
   
 
  
19. Kwezi nyanga zili-12 ezigqithileyo kukamgaphi ubuncinane,ugcinwa uhleli ebusuku 
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             Ewe    Hayi 
20. Wakha wanayo I-eczema? 
 








Ubunzima bomzimba:  kg  
 
Ubude:  iiSentimitha  
 
3. Kwezi nyanga zili -12 zigqithileyo, uzitye  kangaphi,  ubuncinane ezi  zidlo zilandelayo?:  
 (Nceda ushiye kungabhalwanga ukuba akukwazi oko kutya kubuzwayo)  









 Inyama(umz. Yenkomo, yegusha, yenkukhu, 
yehagu)  
      
       
 Ukutya kwasolwandle (kudibanisa nentlanzi)       
       
 Iziqhamo       
       
 Imifuno/ iiveji (zonke iintlobo)        
       
 Ii-erentyisi, iimbotyi        
       
 iiCereal (kudibanisa nesonka)        
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 umbona (uMielie meal, umgubo)       
       
 iPasta        
       
 IRice       
       
 iBhotolo        
       
 iMargarine        
       
  Amandongomane       
       
 ii-tapile        
       
 ubisi        
       
 amaqanda        
       




4. Uthamba kangaphi ngeveki  okanye uwenza kangaphi  umsebenzi onzima ukukwenza 
uphefumle nzima?:  
 Zange okanye nqabileyo   
   
                                                    Kanye okanye kabini ngeveki       
   
                                               Kathathu nangaphezulu ngeveki   
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                       Ngaphantsi kwe yure enye   
   
                                            Iyure enye nangaphantsi kweeyure ezi ntathu   
   
                                      Iiyure ezintathu nangaphantsi kweeyure ezintlanu   
   
 Iiyure ezi ntlanu nangaphezulu   
 
6. Endlwini kokwenu nisebenzisa esiphi isibasi ngokuqhelekileyo xa niphekayo?: 
  Umbane   
   
 i-Rasi   
   
 i-Paraffin   
   
 Iinkuni    
   
 esinye- nceda cacisa   
 
7. Endlwini, kokwenu nisebenzisa esiphi isibasi ngokuqhelekileyo okwenza shushu?: 
 Umbane   
   
 I-Rasi   
   
 i-Paraffin   
   
 Iinkuni   
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8. Kwezi nyanga zili-12 zigqithileyo uzisele kangaphi ubuncinane, iiPanado?: 
 
 Zange    
   
                                                   Kanye ngonyaka ubuncinane   
   
                                                   Ubuncinane kanye ngenyanga.   
9.  Bangaphi abakhuluwa noodade wenu  abakhulu?:  Oodade nabakhuluwa 
 
 
 10.  Bangaphi abaninawe noodade wenu abancinane?:  Odade nabaninawe 
 
 
11.  Ingaba wazalelwe e-Kapa?: 
 
 Ewe   
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 I-Primari skolo   
   
 Isikolo samabanga aphezulu (high school)   
   
 I-Kholeji, idyunivesiti, okanye olunye uhlobo lwemfundo enomsila   
 
 
14.Ufike/ ugqibe eliphi ibanga lemfundo utata wakho?: 
 I- primari skolo   
   
 Isikolo samabanga aphezulu (high school)   
   
 I-kholeji, idyunivesiti okanye uhlobo lwemfundo enomsila   
 
15. Zigqitha kangaphi ii- truck kwisitrato ohlala kuso kwiintsuku zeveki? 
  
                                             Azigqithi konke konke   
   
 Nqabileyo   
   
 Qho imini yonke   
   
 
16. Kwezi nyanga zili-12 zigqithileyo ukhe wanayo ikati ekhayeni lakho?: 
 Ewe   
   
 Hayi   
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  Ewe   
   
 Hayi   
 
18. Ingaba uyazitshaya iisigarethi umama okanye umgcini wakho obhinqileyo?: 
  Ewe   
   
 Hayi   
 
19. Ingaba uyazitshaya iisigarethi utata wakho okanye umgcini wakho oyindoda?: 
 Ewe   
   
 Hayi   
 
 
20.    Bangaphi abantu  abatshaya iisigarethi abahlala endlwini kokwenu ?:  Yabantu 
 
21.  Uyazitshaya wena ii-sigarethi?: 
  Ewe   
   
 Hayi   
 
 
22. Ingaba indlu yenu imanzi okanye ifumile ngaphakathi?: 
 Ewe   
   
 Hayi   
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 Ewe   
   
 Hayi   
 
24. Ingaba wena wakha wanyangelwa iTB?:   
 Ewe   
   
 Hayi   
 
25. Bangaphi abantu abahlala endlini yakokwenu?: 
 Abantu abakhulu    
   
 Abantwana   
   
 
26. Ingaba ninazo Ii- tepu zamanzi abalekayo endlwini yakokwenu?: 
 Ewe   
   
 Hayi   
 
 
27.    Ingaba ninawo umbane indlwini kokwenu?: 
  Ewe   
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  Ewe   
   
 Hayi   
 
29.   Ingaba unekhaya elinjani?: 
 Indlu     
    
 i-flat    
    
 Ityotyombe    
    
                                               Enye Cacisa     
    
 
 
30.   Ingaba bangaphi  abantu abahlala kokwenu abaphangela ngokuqhelekileyo?:  Yabantu 
 
 





32.  Bangaphi abantu ababelana nawe ngegumbi lokulala ebusuku?:  Yabantu 
 
 
Yima apha linda  de kuqaliswe umfanekiso we video phambi kokuphendulaimibuzo elandelayo. 
 
 
Yima ulinde umfanekiso we-video phambi kokuphendula. 
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 Ukuphefumla kwakho kukhe kwanjena?    
    
 Ukuba uthi EWE, ibikhe yenzeka lento kulonyaka ophelileyo?    
    
 Ukuba uthi EWE, ibikhe yenzeka kanye okanye kaninzi ngenyanga?    
 Ewe  Hayi 
 Emva kokuthamba kukhe ukuphefumla kwakho kwafana nokwala  
 nkwenkwe inxibe ihempe emdaka, nangaliphi ixesha ebomini bakho? 
 
   
    
 Ukuba uthi EWE, ibikhe yenzeka lento kulonyaka ophelileyo?    
    
 Ukuba  uthiEWE, ibikhe yenzeka kanye okanye kaninzi ngenyanga?    
 Ewe  Hayi 
 Wakha wavuka unjena ebusuku, nangaliphi ixesha ebomini bakho?    
    
 Ukuba kunjalo, ibikhe yenzeka lento kulonyaka ophelileyo?    
    
 Ukuba kunjalo, ibikhe yenzeka kanye okanye kaninzi ngenyanga?    
 Ewe  Hayi 
 Wakha wavuka unjena ebusuku? 
 
   
    
 Ukuba kunjalo, ibikhe yenzeka lento kulonyaka ophelileyo?    
    
 Ukuba kunjalo, ibikhe yenzeka kanye okanye kaninzi ngenyanga?    
 Ewe  Hayi 
 Wakhe waphefumla kanjena, nangaliphi ixesha ebomini bakho?    
    
 Ukuba  uthi EWE, ibikhe yenzeka lento kulonyaka ophelileyo?    
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Appendix 1G: Questionnaire (Afrikaans version) 
 
OPNAME VAN ASEMHALINGS, NEUS EN VELPROBLEME 
                                     
Alleenlik vir kantoorgebruik          
 
VII. Aanwysings vir die voltooing van die vraelys 
Hierdie vraelys bevat vrae met betrekking tot jou naam, adres en geboortedatum.  Skryf asseblief jou 
antwoorde neer in die spasies voorsien.   
Al die ander vrae moet beantwoord word deur ’n merkie in die blokkie te maak wat jy kiesof die 
antwoord in die blokkie te skryf.  Indien jy jou antwoord wil verander, trek net ’n kruisie deur die 
blokkie en merk dan die regte een.  Merk slegs een blokkie per vraag. 
Hier is n voorbeeld:               Ouderdom 
                                                                            jaar 
                                                                              
  Ja         Nee 
Om ja of nee te antwoord, plaas net ’n merkie   




Naam:     
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Vandag se datum: 






 Dag  Maand  Jaar 
 
Jou geslag:  
 
                                                    Seun               Meisie 
 
Is jy in Kaapstad gebore?     Ja       Nee 
 
 
Indien jy nie in Kaapstad gebore is nie, op watter            
ouderdom het jy hierheen verhuis?  
 
                                                                                        Jaar 
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 Ja   Nee 
1. Het jy al ooit ’n fluit of hygbors gehad?    
    
     
7. INDIEN JY “NEE” GEANTWOORD HET, GAAN DIREK NA VRAAG 6 
 
 
 Ja      Nee 
2.  Het jy ’n fluit of hygbors gedurende die afgelope 12 maande gehad?    
 
INDIEN JY “NEE” GEANTWOORD HET, GAAN DIREK NA VRAAG 6 
 
3.  Hoeveel aanvalle van fluit of hygbors het jy in die afgelope 12 maande gehad? 




        
 







Minder as 1 
keer per 
week 
1 of meer 
nagte per 
week 
         
 
  Ja     Nee 
5.  Was die fluit of hygbors ooit so erg die afgelope 12 maande, dat jy slegs 1 of 2 
woorde per asemtog kon praat?   
   
   
  Ja     Nee 
6.. Het jy al ooit asma gehad? 
 
   
 
 
 Ja      Nee 
7.  Het jou bors in die afgelope 12 maande gefluit gedurende of na oefening?    
 
 Ja      Nee 
14. Het jy gedurende die afgelope 12 maande ooit ’n droë hoes gedurende die 
nag 
ervaar buiten wanneer jy ’n verkoue of griep gehad het? 
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DIE VOLGENDE VRAE HANDEL OOR SIMPTOME WAT JY ERVAAR HET, MAAR NIE 
TEN TYE VAN ’N VERKOUE OF GRIEP NIE. 
 Ja       Nee 
9.  Het jy al ooit ’n probleem met ’n geniesery, loop of toeneus gehad, buiten 
wanner jy verkoue of griep gehad het? 
   
 
INDIEN JY “NEE” GEANTWOORD HET, GAAN DIREK NA VRAAG 14 
 Ja      Nee 
10.  Het jy in die afgelope 12 maande probleme met ’n geniesery, loop of 
toeneus gehad, wanneer jy nie verkoue of griep gehad het nie?  
   
 
INDIEN JY “NEE” GEANWOORD HET, GAAN DIREK NA VRAAG 14 
 
  Ja     Nee 
11.  Het jou neusprobleem in die afgelope 12 maande gepaard gegaan met 
jeukerige/tranerige oë 
   
 
 
15. Gedurende watter van die afgelope 
12 maande het jou neusprobleme 
geduur? 
(Dui asseblief almal aan wat van toepassing 
is) 
Januarie Februarie Maart April 
            
Mei Junie Julie Augustus 
            
September Oktober November Desember 
            
 
 
13.  Hoe dikwels het jou neusprobleme in die 
afgelope 12 maande jou daaglikse aktiwiteite 
beïnvloed 
Glad nie  Effens   Taamlik baie  Baie  




 Ja       Nee 
16.  Het jy al ooit hooikoors gehad? 
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  Ja   Nee 
15.  Het jy al ooit ’n jeukerige veluitslag gehad wat gekom  gaan het oor tenminste 6 
maande? 
   
 
8. INDIEN JY “NEE” GEANTWOORD HET, GAAN DIREK NA VRAAG 20 
 
 
                                                                                                                           Ja     Nee 
17. Het jy hierdie jeukerige uitslag die afgelope 12 maande gehad? 
 
   
 
9. INDIEN JY “NEE” GEANTWOORD HET, GAAN DIREK NA VRAAG 20 
 
 
                                                                                                                           Ja     Nee 
17.  Het hierdie jeukerige uitslag enige van die volgende areas aangetas?:    
Die elmboë se voue, agter die knieë, aan die voorkant van die enkels,  
onder die boude, om die nek, ore of oë? 
 
 
 Ja Nee 
18.  Het hierdie uitslag ooit gedurende die afgelope 12 maande totaal opgeklaar?    
 
  
19.  Hoe gereeld het die jeukerige uitslag jou gedurende die afgelope 12 maande snags wakker gehou?   
Nooit in die 
afgelope 12 
maande nie 
Minder as 1 
keer per 
week 
1 of meer 
keer per 
week 




                                                                                                                          Ja      Nee 
20.  Het jy al ooit ekseem gehad? 
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LAAT NEEM JOU MASSA EN LENGTE VOORDAT JY VERDER GAAN 
 
 
9. Massa:  kg  
 
10. Lengte:  cm 
 
11. Gedurende die afgelope 12 maande, hoe dikwels het jy die volgende geëet of drink?  
 (Laat asseblief ’n spasie indien jy nie die voedselsoort ken nie)  
Nooit of af en 
toe 





 Vleis (bv. Bees, lam, hoender, vark)        
       
 Seekos (insluitend vis)       
       
 Vrugte       
       
 Groente (alle soorte)        
       
 Erte, bone        
       
 Graankos (insluitend brood)        
       
 Mielies (mieliemeel)       
       
 Pasta        
       
 Rys       
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 Botter        
       
 Margarien       
       
 Neute (insluitend grondbone)       
       
 Aartappels        
       
 Melk        
       
 Eiers       
       







12. Hoeveel keer per week doen jy oefeninge of fisiese arbeid wat jou hard laat asemhaal?  
  Nooit of soms   
   
 Een of tweekeer per week   
   
 Drie of meerkeer per week   
 
13. Gedurende ’n normale week, hoeveel uur per dag kyk jy televisie?: 
 Minder as ’n uur   
   
 1 uur of meer, maar minder as 3 ure   
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 5 ure of meer   
 
14. Watter tipe brandstof word in jou huis gebruik vir koskook?: 
  Elektrisiteit   
   
 Gas   
   
 Paraffien   
   
 Hout (insluitend oop vure)   
   
 Ander – spesifiseer asseblief   
 
15. Watter tipe brandstof word in jou huis gebruik vir verhitting?: 
  Elektrisiteit   
   
 Gas   
   
 Paraffien   
   
 Hout (insluitend oop vure)   
   
 Ander – spesifiseer asseblief   
 
 
16. Hoeveel keer gedurende die afgelope 12 maande het jy Panado gedrink?: 
 
  Nooit    
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 Ten minste 1 keer per jaar   
   
 Ten minste 1 keer per maand   
 
9.  Hoeveel ouer broers en susters het jy?  Broers en susters 
 
10.  Hoeveel jonger broers en susters het jy?  Broers en susters 
 
18. Is jy in Suid Afrika gebore?: 
 
  Ja   
   
 Nee   
 
12.  Hoeveel lank woon jy al in Suid Afrika?:  jaar 
 
19. Watter vlak van opleiding het jou moeder bereik or voltooi?: 
  Primêre skool   
   
 Hoër skool   
   
 Kollege, universiteit of ander vorm van tersiëre opleiding   
 
20. Watter vlak van opleiding het jou vader bereik of voltooi?: 
  Primêre skool   
   
 Hoër skool   
   















21. Hoe dikwels ry vragmotors in die straat af waar jy woon?:  
  Nooit   
   
 Selde   
   
 Gereeld gedurende die dag   
   
 
16  Het julle die afgelope 12 maande ’n kat in die huis gehad?: 
 Ja   
   
 Nee   
 
17.  Het julle die afgelope 12 maande ’n hond in die huis gehad?: 
 Ja   
   
 Nee   
 
18.  Rook jou moeder (of die vroulike persoon wat na jou kyk) sigarette?: 
 Ja   
   
 Nee   
 
19. Rook jou vader (of die manlike persoon wat na jou kyk) sigarette?: 
  Ja   
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20. Hoeveel inwoners van jou huis, rook sigarette  inwoners 
 
21. Rook jy sigarette?: 
 Ja   
   
 Nee   
 
 
22. Is jou huis aan die binnekant, klam of nat?:  
 Ja   
   
 Nee   
 
23. Het enige een in jou huis al ooit TB gehad?: 
 Ja   
   
 Nee   
 
24. Is jy al ooit vir TB behandel?:   
  Ja   
   
 Nee   
25. Hoeveel mense woon in jou huis?: 
 Volwassenes   
   
 Kinders   
   
 
 
26. Is daar krane met lopende water in jou huis?: 
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Nee 
27. Is daar elektrisiteit in jou huis?:
Ja 
Nee 
28. Is daar ’n TV in jou huis?:
Ja 
Nee 





30. Hoeveel inwoners van jou huis het ’n vaste betrekking?: inwoners 
31. Hoeveel inwoners van jou huis is werkloos of opsoek na werk?: inwoners 






















 Ja  Nee 
2. Was jou asemhaling al ooit soos die van die seun met die donker hemp na 
oefening? 
   
    
Indien JA, het dit die afgelope jaar gebeur?    
    




 Ja  Nee 
1. Was jou asemhaling al soos dié?:    
    
Indien JA, het dit die afgelope jaar gebeur?    
    
Indien JA, het dit een of meerkeer per maand gebeur?    
 Ja  Nee 
3. Het jy ooit in jou lewe snags so wakker geskrik?    
    
Indien JA, het dit die afgelope jaar gebeur?    
    
















 Ja  Nee 
4. Het jy al ooit soos dié gedurende die nag wakker geword?    
    
Indien JA, het dit die afgelope jaar gebeur?    
    
Indien JA, het dit een of meerkeer per maand gebeur?    
 Ja  Nee 
5. Was jou asemhaling al ooit soos dié?    
    
Indien JA, het dit die afgelope jaar gebeur?    
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Appendix II: Online Repository Materials 
Table i: Prevalence estimates of all sociodemographic variables 
Variable Responses (N=5,037) Percentage (%) 
Medium of instruction at school 
Afrikaans 1,289 25.59 
English 2,059 40.88 
Xhosa 1,689 33.53 
Age 
≤13 years 2,604 51.70 
≥14 years 2,432 48.28 
Gender 
Male 2, 026 40.20 
Female 2, 995 59.5 
Invalid 16 0.32 
Cape Town city of birth 
Yes 4, 074 80.88 
No 934 18.54 
Invalid 29 0.58 
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Variable Responses (N=5,037) Percentage (%) 
Primary school 922 18.30 
High school 2, 960 58.77 
College, university or other 
form of tertiary education 
1, 086 21.56 
What level of education has your father reached or completed? 
Primary school 865 17.17 
High school 2, 571 51.04 
College, university or other 
form of tertiary education 
1, 313 26.07 
≥4 1, 541 30.59 
Invalid 456 9.05 
Do you have a TV in your house? 
Yes 4, 504 89.42 
No 346 6.87 
No response 187 3.71 
How many people in your household are working? 
0 289 5.74 
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Variable Responses (N=5,037) Percentage (%) 
2 1, 707 33.89 
3 598 11.87 
≥4 352 6.99 
Invalid 542 10.76 
How many people in your household are not working? 
0 1, 652 32.80 
1 1, 507 29.92 
2 724 14.37 
3 251 4.98 
≥4 150 2.98 
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Table ii: Prevalence estimates of all diet variables 
Diet in past 12 months Never or rarely (%) Once or twice per week (%) Three or more times a week (%) Missing (%) 
Meat 339 (6.73) 2, 095 (41.59) 2, 431 (48.26) 172 (3.41) 
Seafood 2, 174 (43.16) 2, 184 (43.36) 391 (7.76) 288 (5.72) 
Fruit 335 (6.65) 1, 421 (28.21) 3, 092 (61.39) 189 (3.75) 
Vegetables 613 (12.17) 1, 648 (32.72) 2, 549 (50.61) 227 (4.51) 
Peas, beans 1, 561 (30.99) 2, 274 (45.15) 929 (18.44) 273 (5.42) 
Cereal 459 (9.11) 842 (16.72) 3, 438 (68.25) 298 (5.92) 
Maize 2, 224 (44.15) 1, 651 (32.78) 879 (17.45) 283 (5.62) 
Pasta  1, 332 (26.44) 2, 434 (48.32) 827 (16.42) 444 (8.81) 
Rice 253 (5.02) 1, 155 (22.93) 3, 445 (68.39) 184 (3.65) 
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Margarine 1, 267 (25.15) 1, 384 (27.48) 1, 979 (39.29) 407 (8.08) 
Nuts 1, 951 (38.73) 1, 976 (39.23) 833 (16.54) 277 (5.50) 
Potatoes 203 (4.03) 1, 292 (25.65) 3, 339 (66.29) 203 (4.03) 
Milk 444 (8.81) 1, 317 (26.15) 3, 065 (60.85) 211 (4.19) 
Eggs 672 (13.34) 2, 530 (50.23) 1, 588 (31.53) 247 (4.90) 
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Table iii: Prevalence estimates of all other environmental exposures 
How many times a week do you have enough exercise or physical effort to make you breathe 
hard? 
Never or occasionally 1, 572 31.21 
Once or twice per week 2, 103 41.75 
Three or more times a week 1, 181 23.45 
Missing 181 3.59 
During a normal week, how many hours a day do you watch television? 
Less than 1 hour 563 11.18 
1 hour but less than 3 hours 1, 303 25.87 
3 hours but less than 5 hours 1, 353 26.86 
5 hours or more 1, 620 32.16 
In your house, what fuel is usually used for cooking? 
Electricity 4, 436 88.07 
Gas 503 9.99 
Paraffin 892 17.71 
Wood 83 1.65 
Other 1 0.02 
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Electricity        3, 540 70.28 
Gas 231 4.59 
Paraffin 1, 177 23.37 
Wood 303 6.02 
Other 19 0.38 
In the past 12 months, how often, on average, have you taken Panado? 
Never 1, 333 26. 46 
At least once a year 1, 764 35.02 
At least once per month 1, 741 34.56 
Missing 199 3.95 
How often do trucks pass along the street where you live, on weekdays? 
Never 582 11.55 
Seldom 2, 249 44.65 
Frequently during the day 2, 015 40.00 
Missing 191 3.79 
In the past 12 months, have you had a cat in your home? 
Yes 1, 526 30.30 
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No response 174 3.45 
In the past 12 months, have you had a dog in your home? 
Yes 2, 663 52.87 
No 2, 192 43.52 
No response 182 3.61 
Does your mother (or female care giver) smoke cigarettes? 
Yes 1, 405 27.89 
No 3, 419 67.88 
No response 213 4.23 
Does your father (or male care giver) smoke cigarettes? 
Yes 2, 130 42.29 
No 2, 626 52.13 
No response 281 5.58 
Do you smoke cigarettes? 
Yes 433 8.60 
No 4, 417 87.69 
No response 187 3.71 
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Yes 691 13.72 
No 4, 133 82.05 
No response 213 4.23 
Have you ever been treated for TB? 
Yes 325 6.45 
No 4, 447 88.29 
No response 265 5.26 
How many older brothers and sisters do you have? 
0 900 17.87 
1 1, 371 27.22 
2 933 18.52 
3 544 10.80 
≥4 500 9.93 
Invalid 789 15.66 
How many younger brothers and sisters do you have? 
0 986 19.58 
1 1, 737 34.48 
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3 358 7.11 
≥4 190 3.77 
Invalid 789 15.66 
How many people living in your house smoke cigarettes? 
0 1, 399 27.77 
1 1, 308 25.97 
2 901 17.89 
3 429 8.52 
≥4 447 8.87 
Invalid 553 10.98 
How many adults live in your household? 
1 425 8.44 
2 2, 263 44.93 
3 823 16.34 
≥4 1, 101 21.86 
Invalid 425 8.44 
How many children live in your household? 
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2 1, 298 25.77 
3 1, 233 24.48 
Is your house damp or wet inside? 
Yes 507 10.07 
No 4, 305 85.47 
No response 225 4.47 
Do you have taps for running water in your house? 
Yes         3, 861 76.65 
No 933 18.52 
No response 243 4.82 
Do you have electricity in your house? 
Yes 4, 666 92.63 
No 181 3.59 
No response 190 3.77 
What type of home do you have? 
House 3, 936 78.14 
Flat 263 5.22 
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Other 60 1.19 
Missing 205 4.07 
How many people share your bedroom at night? 
0 1, 201 23.84 
1 1, 285 25.51 
2 1, 078 21.40 
3 544 10.80 
≥4 417 8.28 
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Table iv: Bivariate analysis: allergic rhinitis, atopic eczema and comorbid symptoms with remaining sociodemographic and environmental exposures 
 Allergic Rhinitis Atopic Eczema Allergic Rhinitis and Atopic Eczema 
Exposure n N=5, 
037 











≤13 years 530 2, 604 0.96 0.83-
1.11 
0.60 342 2, 604 1.07 0.90-
1.27 
0.46 121 2, 604 0.93 0.72-
1.20 
0.57 
≥14 years 513 2, 433 1.00   327 2, 433 1.00   123 2, 433 1.00   
What level of education has your father reached or completed? 
Primary 
school 
201 865 1.05 0.87-
1.27 
0.59 127 865 1.05 0.83-
1.31 





537 2, 571 1.03 0.89-
1.19 
0.69 327 2, 571 0.82 0.69-
0.98 





276 1, 313 1.03 0.87-
1.22 
0.71 162 1, 313 1.06 0.86-
1.30 
0.57 56 1, 313 0.86 0.63-
1.17 
0.33 
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 Allergic Rhinitis Atopic Eczema Allergic Rhinitis and Atopic Eczema 
Exposure n N=5, 
037 










0-1 99 425 1.00   71 425 1.00   23 425 1.00   
2 473 2, 263 0.81 0.62-
1.06 
0.13 270 2, 263 0.70 0.51-
0.96 
0.03 99 2, 263 0.82 0.51-
1.31 
0.41 
3 164 823 0.72 0.53-
0.98 
0.04 108 823 0.74 0.51-
1.05 
0.09 41 823 0.89 0.53-
1.51 
0.67 
≥4 233 1, 101 0.82 0.61-
1.10 
0.18 173 1, 101 0.90 0.64-
1.27 
0.54 61 1, 101 1.01 0.61-
1.66 
0.98 
Missing 425     425     425     
How many children live in your household? 
0-1 123 509 1.00   71 509 1.00   34 509 1.00   
2 269 1, 298 0.80 0.61-
1.04 
0.10 149 1, 298 0.82 0.59-
1.14 
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 Allergic Rhinitis Atopic Eczema Allergic Rhinitis and Atopic Eczema 
Exposure n N=5, 
037 










3 276 1, 233 0.89 0.68-
1.16 
0.38 158 1, 233 0.79 0.57-
1.10 
0.17 62 1, 233 0.73 0.47-
1.13 
0.15 
≥4 295 1, 541 0.71 0.55-
0.93 
0.01 237 1, 541 0.96 0.70-
1.31 
0.80 75 1, 541 0.69 0.45-
1.06 
0.09 
Missing 456     456     456     
How many times a week do you have enough exercise or physical effort to make you breathe hard? 
Never or 
occasionally 




456 2, 103 1.19 1.00-
1.42 
0.05 299 2, 103 1.27 1.03-
1.56 






248 1, 181 1.18 0.96-
1.44 
0.11 158 1, 181 1.24 0.97-
1.58 
0.09 46 1, 181 0.93 0.64-
1.37 
0.73 
Missing 181     181     181     










161 | P a g e    A .  D e a r h a m  
 
 Allergic Rhinitis Atopic Eczema Allergic Rhinitis and Atopic Eczema 
Exposure n N=5, 
037 










Less than 1 
hour 
108 563 1.00   78 563 1.00   35 563 1.00   
1 hour but 
less than 3 
hours 
272 1, 303 1.12 0.86-
1.46 
0.42 167 1, 303 0.94 0.69-
1.29 
0.71 58 1, 303 0.70 0.45-
1.08 
0.11 
3 hours but 
less than 5 
hours 
297 1, 353 1.19 0.91-
1.54 
0.20 175 1, 353 0.97 0.71-
1.32 
0.86 72 1, 353 0.84 0.55-
1.27 
0.41 
5 hours or 
more 
342 1, 620 1.21 0.94-
1.57 
0.15 228 1, 620 0.98 0.73-
1.32 
0.91 75 1, 620 0.74 0.49-
1.13 
0.16 
Missing 198     198     198     
Were you born in South Africa? 
Yes 888 4, 172 1.02 0.81-
1.29 
0.87 535 4, 172 0.62 0.48-
0.79 
0.00 207 4, 172 0.99 0.67-
1.45 
0.96 
No 116 682 1.00   121 682 1.00   32 682 1.00   
No response 183     183     183     
How often do trucks pass along the street where you live, on weekdays? 
Never 119 582 1.00   79 582 1.00   35 582 1.00   
Seldom 461 2, 249 1.04 0.82-
1.33 
0.72 273 2, 249 0.90 0.67-
1.20 
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 Allergic Rhinitis Atopic Eczema Allergic Rhinitis and Atopic Eczema 
Exposure n N=5, 
037 













434 2, 015 1.08 0.85-
1.38 
0.51 295 2, 015 1.00 0.74-
1.33 
0.98 104 2, 015 0.84 0.56-
1.25 
0.39 
Missing 191     191     191     
In the past 12 months, have you had a cat in your home? 
Yes 333 1, 526 0.98 0.83-
1.15 
0.78 210 1, 526 1.00 0.83-
1.21 
0.99 81 1, 526 1.09 0.82-
1.43 
0.56 
No 680 3, 337 1.00   444 3, 337 1.00   156 3, 337 1.00   
No response 174     174     174     
In the past 12 months, have you had a dog in your home? 
Yes 571 2, 663 1.06 0.91-
1.22 
0.48 363 2, 663 0.98 0.82-
1.17 
0.82 138 2, 663 1.13 0.87-
1.48 
0.36 
No 446 2, 192 1.00   288 2, 192 1.00   100 2, 192 1.00   
No response 182     182     182     
Does your father (or male care giver) smoke cigarettes? 
Yes 473 2, 130 1.07 0.92-
1.25 
0.36 297 2, 130 0.99 0.82-
1.18 
0.89 125 2, 130 1.36 1.04-
1.78 
0.02 
No 520 2, 626 1.00   340 2, 626 1.00   111 2, 626 1.00   
No response 281     281     281     










163 | P a g e    A .  D e a r h a m  
 
 Allergic Rhinitis Atopic Eczema Allergic Rhinitis and Atopic Eczema 
Exposure n N=5, 
037 










0 192 900 1.00   144 900 1.00   45 900 1.00   
1 296 1, 371 0.92 0.73-
1.15 
0.44 189 1, 371 0.75 0.58-
0.97 
0.03 71 1, 371 1.01 0.69-
1.49 
0.95 
2 172 933 0.74 0.58-
0.95 
0.02 107 933 0.58 0.43-
0.78 
0.00 35 933 0.71 0.45-
1.12 
0.15 
3 123 544 1.02 0.77-
1.34 
0.93 75 544 0.77 0.55-
1.07 
0.12 35 544 1.32 0.84-
2.10 
0.23 
≥4 103 500 0.90 0.67-
1.21 
0.50 83 500 0.90 0.65-
1.25 
0.53 29 500 1.15 0.71-
1.86 
0.58 
Missing 789     789     789     
How many younger brothers and sisters do you have? 
0 209 986 1.00   134 986 1.00   49 986 1.00   
1 369 1, 737 0.86 0.70-
1.06 
0.16 230 1, 737 0.92 0.72-
1.18 
0.52 81 1, 737 0.90 0.62-
1.30 
0.57 
2 180 977 0.75 0.59-
0.96 
0.02 157 977 1.06 0.81-
1.39 
0.67 50 977 0.98 0.65-
1.47 
0.91 
3 73 358 0.88 0.64-
1.22 
0.45 50 358 0.90 0.61-
1.32 
0.58 20 358 1.12 0.65-
1.93 
0.68 
≥4 43 190 1.04 0.69-
1.56 
0.85 36 190 1.15 1.74-
1.80 
0.53 10 190 0.96 0.48-
1.95 
0.92 
Missing 789     789     789     
How many people living in your house smoke cigarettes? 
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 Allergic Rhinitis Atopic Eczema Allergic Rhinitis and Atopic Eczema 
Exposure n N=5, 
037 










1 263 1, 308 0.91 0.74-
1.11 
0.36 195 1, 308 1.03 0.81-
1.31 
0.83 65 1, 308 1.32 0.91-
1.93 
0.15 
2 178 901 0.81 0.65-
1.02 
0.07 108 901 0.72 0.55-
0.95 
0.02 42 901 1.21 0.79-
1.84 
0.38 
3 108 429 1.18 0.90-
1.57 
0.23 56 429 0.72 0.51-
1.02 
0.07 26 429 1.57 0.96-
2.56 
0.07 
≥4 117 447 1.07 0.82-
1.39 
0.63 57 447 0.66 0.47-
0.93 
0.02 31 447 1.73 1.09-
2.75 
0.02 

























165 | P a g e    A .  D e a r h a m  
 
Table v: Bivariate analysis: allergic rhinitis, atopic eczema and comorbid symptoms with remaining dietary exposures 
 
 Allergic Rhinitis Atopic Eczema Allergic Rhinitis and Atopic Eczema 




n N=5,037 OR 95% CI p - 
value 
n N=5,037 OR 95% CI p - 
value 
Meat-1 72 339 1.00   53 339 1.00   25 339 1.00   
Meat-2 416 2, 095 0.89 0.65-
1.20 
0.43 259 2, 095 0.89 0.63-
1.26 
0.52 87 2, 095 0.55 0.35-0.88 0.01 
Meat-3 529 2, 431 1.08 0.80-
1.47 
0.60 337 2, 431 0.99 0.71-
1.39 
0.97 125 2, 431 0.71 0.45-1.11 0.13 
Meat-9 172     172     172     
Seafood-1 455 2, 174 1.00   263 2, 174 1.00   107 2, 174 1.00   
Seafood -2 450 2, 184 1.00 0.85-
1.17 
0.99 308 2, 184 1.20 0.99-
1.45 
0.06 107 2, 184 1.02 0.77-1.34 0.91 
Seafood -3 93 391 1.17 0.89-
1.54 
0.26 63 391 1.10 0.80-
1.51 
0.58 19 391 0.90 0.54-1.49 0.68 
Seafood -9 288     288     288     
Fruit-1 82 335 1.00   44 335 1.00   18 335 1.00   
Fruit-2 291 1, 421 0.73 0.54-
0.99 
0.05 183 1, 421 0.98 0.67-
1.43 
0.90 67 1, 421 0.88 0.51-1.50 0.63 
Fruit-3 641 3, 092 0.75 0.56-
1.01 
0.06 414 3, 092 1.03 0.72-
1.48 
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Fruit-9 189     189     189     
Maize-1 504 2, 224 1.00   237 2, 224 1.00   84 2, 224 1.00   
Maize -2 297 1, 651 0.79 0.67-
0.94 
0.01 231 1, 651 1.35 1.09-
1.66 
0.01    84 1, 651 1.39 1.02-1.90 0.04 
Maize -3 190 879 1.02 0.83-
1.26 
0.84 163 879 1.79 1.41-
2.27 
0.00 61 879 1.86 1.32-2.62 0.00 
Maize -9 283     283     283     
Pasta-1 257 1, 332 1.00   208 1, 332 1.00   66 1, 332 1.00   
Pasta -2 537 2, 434 1.04 0.87-
1.24 
0.64 283 2, 434 0.69 0.56-
0.86 
0.01 110 2, 434 0.89 0.65-1.22 0.49 
Pasta -3 181 827 0.98 0.78-
1.23 
0.85 120 827 0.72 0.55-
0.94 
0.02 52 827 1.19 1.82-1.74 0.36 
Pasta -9 444     444     444     
Rice-1 51 253 1.00   45 253 1.00   18 253 1.00   
Rice-2 211 1, 155 0.99 0.69-
1.41 
0.94 128 1, 155 0.70 0.46-
1.05 
0.08 48 1, 155 0.65 0.37-1.14 0.13 
Rice-3 745 3, 445 1.25 0.89-
1.75 
0.19 463 3, 445 0.77 0.53-
1.11 
0.16 169 3, 445 0.75 0.45-1.24 0.26 
Rice-9 184     184     184     
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Butter-2 206 1, 125 0.90 0.71-
1.15 
0.41 163 1, 125 1.11 0.84-
1.47 
0.46 56 1, 125 1.24 0.81-1.91 0.32 
Butter- 3 599 2, 710 1.10 0.90-
1.35 
0.36 341 2, 710 0.90 0.70-
1.14 
0.39 131 2, 710 1.19 0.81-1.73 0.37 
Butter-9 286     286     286     
Margarine-
1 
262 1, 267 1.00   145 1, 267 1.00   58 1, 267 1.00   
Margarine-
2 
272 1, 384 0.96 0.79-
1.18 
0.71 195 1, 384 1.30 1.01-
1.65 
0.05 69 1, 384 1.10 0.76-1.57 0.62 
Margarine- 
3 
431 1, 979 1.13 0.94-
1.36 
0.20 272 1, 979 1.26 1.00-
1.59 
0.05 101 1, 979 1.12 0.80-1.56 0.51 
Margarine-
9 
407     407     407     
Nuts-1 396 1, 951 1.00   239 1, 951 1.00   94 1, 951 1.00   
Nuts-2 411 1, 976 1.05 0.89-
1.24 
0.53 252 1, 976 0.98 0.80-
1.21 
0.89 85 1, 976 0.89 0.66-1.21 0.47 
Nuts- 3 177 833 1.09 0.88-
1.35 
0.45 132 833 1.15 0.89-
1.47 
0.28 48 833 1.16 0.81-1.67 0.41 
Nuts-9 277     277     277     
Potatoes-1 37 203 1.00   29 203 1.00   9 203 1.00   
Potatoes-2 252 1, 292 1.28 0.75-
1.69 
0.56 158 1, 292 1.01 0.64-
1.60 














714 3, 339 1.28 0.87-
1.89 
0.21 445 3, 339 1.05 0.68-
1.63 
0.81 177 3, 339 1.29 0.65-2.57 0.47 
Potatoes-9 203     203     203     
Milk-1 95 444 1.00   71 444 1.00   26 444 1.00   
Milk-2 241 1, 317 0.89 0.67-
1.19 
0.43 193 1, 317 0.96 0.69-
1.32 
0.80 59 1, 317 0.80 0.49-1.29 0.36 
Milk- 3 671 3, 065 1.00 0.77-
1.29 
0.97 375 3, 065 0.80 0.56-
0.93 
0.15 150 3, 065 0.86 0.56-1.33 0.51 
Milk-9 211     211     211     
Eggs-1 144 672 1.00   90 672  1.00  34 672 1.00   
Eggs-2 517 2, 530 0.95 0.76-
1.19 
0.65 280 2, 530 0.80 0.61-
1.06 
0.11 101 2, 530 0.80 0.54-1.19 0.28 
Eggs- 3 337 1, 588 1.09 0.86-
1.38 
0.48 258 1, 588 1.20 0.91-
1.60 
0.20 96 1, 588 1.24 0.83-1.87 0.29 
Eggs-9 247     247     247     
Fastfood-1 181 980 1.00   122 980 1.00   42 980 1.00   
Fastfood-2 497 2, 384 1.12 0.91-
1.37 
0.27 284 2, 384 0.87 0.68-
1.11 
0.26 110 2, 384 1.08 0.75-1.55 0.70 
Fastfood- 3 305 1, 326 1.15 0.92-
1.43 
0.23 207 1, 326 1.00 0.77-
1.30 
0.99 73 1, 326 1.18 0.80-1.75 0.40 
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